The Role of ATP-dependent Chromatin Remodeling Enzyme CHD7 in the Development and Maintenance of Murine Neural Stem Cells. by Micucci, Joseph Anthony
 
The role of ATP-dependent chromatin remodeling enzyme CHD7 in the 
development and maintenance of murine neural stem cells 
by 
Joseph Anthony Micucci 
 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
(Biological Chemistry) 














Associate Professor Donna M. Martin, Co-Chair 
 Adjunct Assistant Professor Daniel A. Bochar, Co-Chair 
 Assistant Professor Shigeki Iwase 
 Associate Professor Raymond C. Trievel 
Professor Michael D. Uhler 






When I heard the learn’d astronomer;   
When the proofs, the figures, were ranged in columns before me;   
When I was shown the charts and the diagrams, to add, divide, 
and measure them;   
When I, sitting, heard the astronomer, where he lectured with much applause in 
the lecture-room,   
How soon, unaccountable, I became tired and sick;           
Till rising and gliding out, I wander’d off by myself,   
In the mystical moist night-air, and from time to time,   
Look’d up in perfect silence at the stars. 
 
Walt Whitman 




Never give up! Trust your instincts! 
Peppy Hare 























To Kristen,  
Thank you for supporting me and keeping me grounded for the last 10 years, 





 First, I would like to thank my incredible wife, Kristen.  I have no idea how 
we made it through the last five and a half years with our marriage and 
happiness intact.  I think we would both agree that the cats were excellent 
arbiters.  There is absolutely no way that I could have finished graduate school 
without you.  You are the motivating and grounding force in my life for which I am 
eternally grateful; otherwise, I would never accomplish anything besides being 
comfortable on the couch watching football.  I will do my best to ensure that the 
next phase in our lives goes much more smoothly and pleasantly than the 
previous. 
 There are no words that can adequately express my gratitude to my 
parents for their unrelenting positivity and unconditional love throughout my life.  
Despite all of the precocious shenanigans I put you through in the early years of 
grade school, having you drive me up and down the East Coast to play hockey 
and paying for my education at Penn State (granted, you two had almost as 
much fun there as I did), you have never once been anything less than 
supremely supportive by letting me make my own life decisions and learn from 
my mistakes.  Thank you to my grandparents for always being there for me 
regardless of their geographical location.  I would also like to thank my family for 
their all of their love and support.  I have to specifically thank Aunt Peg and Uncle 
iv 
 
Joe for their hospitality whether Kristen and I were with them in South Bend, Ann 
Arbor or Pittsburgh.  We both really appreciated being treated like one of your 
own children whenever we were at your house for holidays that we couldn’t make 
it back to Jersey or Philly. 
 Thank you to all of our friends back East (and West now for Robert and 
Imee) for always meeting us at crazy hours and locations during the holidays and 
our brief vacations.  I look forward to making up for lost time when we return to 
Philadelphia. 
 I would also like to thank my friends and lab mates in Ann Arbor.  Thanks 
to Joel and Bruce for their excellent ability to help me forget about things that are 
troubling me, largely through ridiculous conversations and excessive amounts of 
playing video games.  At times, I’m still completely shocked that we all graduated 
in reasonable amounts of time.  I would like to thank everyone that I have worked 
with in the Martin Lab, specifically Wanda, Mindy, Mark, Jennifer, Ethan and 
Sophie.  It was a pleasure to come to lab and deal with such fun people.  I 
retroactively apologize for my insane sense of humor and relative lack of filter.   
I don’t think there is enough space in this dissertation to thank Liz Hurd.   
Our relationship started out as that of master and apprentice and evolved into 
some bizarre amalgamation of sister/mother/work-wife.  Whatever it was, thank 
you for it!  I don’t think I would have adequately made the transition from Dan’s 
lab to Donna’s lab without your guidance.  Kristen and I greatly appreciate your 
hospitality and absorbing us into your family.  I’m also sorry for putting your cat in 
a bag and for him giving me necrotizing fasciitis.   
v 
 
I also need to thank Becky Simon for always being up for crying in our 
beers/Captain and Coke’s whenever I needed it.  Our friendship may have begun 
on that fateful van ride to Kalamazoo first year with discussions of diabetes, 
Wilford Brimley and Crohn’s disease, but I think it was solidified when both of us 
were crying when Penn State locked up the Rose Bowl bid in 2008.  Granted, I 
was crying because my alma mater won the Big Ten championship and you were 
crying because the Spartans had just been curbstomped by four touchdowns at 
the feet of the Nittany Lions, but whatever.  
I would also like to thank my thesis committee: Ray Trievel, Mike Uhler, 
Anne Vojtek, Shigeki Iwase and Tom Glaser.  Without your patience and 
guidance throughout the last five years, I would not be prepared to write a 
dissertation and defend it.   
 Lastly, I would like to thank my mentors.  Dan, thank you for giving me the 
freedom to be myself, make mistakes and learn from them.  It’s sad that I didn’t 
get to finish my thesis research in your lab, but I thoroughly enjoyed every 
second that I got to learn from you.  Donna, thank you for giving me boundaries 
when I needed them and putting me into the right positions to succeed.  Also, 
thank you for taking me in when I needed help the most.  I know that  we don’t 
often see things the same way, but I’m fairly certain that we’ve learned a great 
deal from eachother.  I couldn’t have asked for better mentors, despite being 
polar opposite in your outlooks on life and science.  You two were exactly what I 





Table of Contents 
Conte 
Dedication .............................................................................................................ii 
Acknowledgements .............................................................................................. iii 
List of Figures .......................................................................................................ix 
List of Tables ........................................................................................................xi 
Abstract ............................................................................................................... xii 
Chapter 1: Introduction ........................................................................................ 1 
SVZ neural stem cell function during corticogenesis ......................................... 1 
SVZ neural stem cell function during olfactory bulb neurogenesis .................... 3 
Signaling pathways in SVZ neurogenesis ......................................................... 5 
     Wnt Signaling ............................................................................................... 5 
     Growth Factor Signaling ............................................................................... 6 
     Hedgehog Signaling ..................................................................................... 7 
     Retinoic Acid Signaling ................................................................................ 8 
Epigenetic regulation of SVZ neurogenesis ...................................................... 9 
     Histone modifying enzymes ....................................................................... 10 
     ATP-dependent chromatin remodeling enzymes ....................................... 11 




CHD family members and their functions in stem cells ................................... 14 
     CHD proteins and embryonic stem cells .................................................... 14 
     CHD proteins and mesenchymal stem cells ............................................... 15 
     CHD proteins and hematopoietic stem cells .............................................. 16 
     CHD proteins and neural stem cells ........................................................... 16 
CHD7 and stem cells ...................................................................................... 18 
CHD7 and CHARGE syndrome ...................................................................... 20 
Novel insights into CHD7 regulation of SVZ neural stem cells ........................ 22 
References ...................................................................................................... 31 
Chapter 2: CHD7 and retinoic acid signaling cooperate to regulate neural stem 
cell and inner ear development in mouse models of CHARGE syndrome .......... 41 
Abstract ........................................................................................................... 41 
Introduction ..................................................................................................... 42 
Materials & Methods ....................................................................................... 44 
Results ............................................................................................................ 54 
Discussion....................................................................................................... 65 
Acknowledgements ......................................................................................... 69 
References ...................................................................................................... 86 
Chapter 3: CHD7 regulates neuronal differentiation and maturation potentially 
through a complex with retinoic acid receptors. .................................................. 91 
Introduction ..................................................................................................... 91 
Materials and Methods .................................................................................... 93 
Results ............................................................................................................ 99 
Discussion..................................................................................................... 105 
Acknowledgements ....................................................................................... 107 
References .................................................................................................... 113 
viii 
 
Chapter 4: Analysis of Chd7 function during murine corticogenesis. ............... 116 
Introduction ................................................................................................... 116 
Materials and Methods .................................................................................. 118 
Results .......................................................................................................... 123 
Discussion..................................................................................................... 127 
Acknowledgements ....................................................................................... 129 
References .................................................................................................... 134 
Chapter 5: Conclusions and Future Directions ................................................ 137 
Summary....................................................................................................... 137 
CHD7 in the perinatal and adult SVZ ............................................................ 138 
CHD7 and retinoic acid signaling .................................................................. 142 
CHD7 and corticogenesis ............................................................................. 146 







List of Figures 
 
Figure 1.1  Morphogenesis of the mouse forebrain throughout development. ... 25 
Figure 1.2  Lineage-specific markers of SVZ-derived cells ................................ 26 
Figure 1.3  Transcriptional regulation by retinoic acid signaling ........................ 27 
Figure 1.4  Distinct histone modifications mark the status of promoter and 
enhancer elements ............................................................................................. 28 
Figure 1.5  Domain schematic of CHD superfamily members ........................... 29 
Figure 1.6  The SOX2/CHD7 complex regulates genes involved in human 
syndromes .......................................................................................................... 30 
Figure  2.1  CHD7 co-localizes with immature and mature olfactory bulb 
neurons. ............................................................................................................. 70 
Figure  2.2  Adult heterozygous Chd7 mice have fewer mature olfactory bulb 
interneurons........................................................................................................ 71 
Figure 2.3  Chd7-deficiency results in fewer immature neurons with glial 
expansion in the adult olfactory bulb. ................................................................. 72 
Figure 2.4  Chd7 is expressed in neural stem cells and neuroblasts in the adult 
mouse SVZ and RMS ......................................................................................... 73 
Figure 2.5  Loss of Chd7 leads to ventriculomegaly and mild proliferative defects 
in the adult mouse SVZ ...................................................................................... 74 
Figure 2.6  Chd7-deficient adult SVZ displays loss of neuroblasts and increased 
glia ...................................................................................................................... 75 
Figure 2.7  Cortex and corpus callosum size are unchanged in adult Nestin-Cre 
conditional Chd7 knockout mice ......................................................................... 76 
Figure 2.8  Neural stem cells derived from adult Chd7 conditional knockout mice 
exhibit impaired proliferation, self-renewal, and neuronal potential .................... 77 
x 
 
Figure 2.9  Reduction of Chd7 dosage leads to decreased adult SVZ-derived 
neurosphere size ................................................................................................ 78 
Figure 2.10  Postnatal day 1 Chd7 conditional knockout mice display reduced 
SVZ proliferation ................................................................................................. 79 
Figure 2.11  Cell cycle and proliferation markers are unchanged with loss of 
Chd7 in the perinatal SVZ .................................................................................. 80 
Figure 2.12  Neurospheres derived from postnatal day 1 Chd7 conditional 
knockout mice exhibit impaired proliferation, self-renewal and neuronal potential
 ........................................................................................................................... 81 
Figure 2.13  Loss of Chd7 results in reduced size of perinatal SVZ-derived 
neurospheres...................................................................................................... 82 
Figure 2.14  Modified retinoic acid signaling influences defects in Chd7-deficient 
neurospheres and semicircular canal development ............................................ 83 
Figure 2.15  Inhibition of retinoic acid signaling by citral prevents semicircular 
canal defects in the developing Chd7-deficient inner ear ................................... 84 
Figure 2.16  CHD7 binds to the promoters of retinoic acid receptor and pro-
neuronal transcription factor genes and regulates their expression .................... 85 
Figure 3.1  CHD7 regulates retinoic acid receptor expression and interacts with 
retinoic acid receptors in vivo ........................................................................... 110 
Figure 3.2  Chd7 reduction leads to growth defects and decreased pro-neural 
gene expression ............................................................................................... 112 
Figure 4.1  CHD7 co-localizes with neural stem and progenitor cells during early 
corticogenesis ................................................................................................... 130 
Figure 4.2  Proliferation and apoptosis are normal in Chd7-deficient SVZ during 
early corticogenesis .......................................................................................... 131 
Figure 4.3  Chd7-deficient forebrain neurospheres display mild proliferative 
defects .............................................................................................................. 132 
Figure 4.4  CHD7 remains expressed in E15.5 SVZ neural stem and progenitor 





List of Tables 
 
Table 3.1  Genes down-regulated in SVZ of Chd7-deficient neonatal mice by 
whole mouse genome microarray. .................................................................... 108 
Table 3.2  Genes up-regulated in SVZ of Chd7-deficient neonatal mice by whole 
mouse genome microarray ............................................................................... 109 
Table 3.3  Gene Ontology terms associated with genes down-regulated in SVZ 








 Cell type-specific gene expression is a tightly controlled process which is 
facilitated by several classes of proteins including transcription factors, histone 
modifying enzymes and ATP-dependent chromatin remodeling enzymes.  The 
CHD class of chromatin remodelers is important for development and 
maintenance of mammalian stem cell populations and their progeny.  In humans, 
haploinsufficiency for the CHD family member CHD7 results in a multiple 
congenital anomaly disorder called CHARGE syndrome.  Defects of the eye, ear, 
heart, brain, olfactory organs and craniofacial features are commonly observed in 
CHARGE syndrome.  Notably, CHARGE individuals display decreased or absent 
sense of smell (hyposmia or anosmia) and small or absent olfactory bulbs (OB) 
and tracts (arrhinencephaly).  The OB is populated by neurons born in a neural 
stem cell niche located along the lateral walls of the lateral ventricles in a region 
termed the subventricular zone (SVZ).  The process of neuronal migration from 
the SVZ to the OB begins during late embryogenesis and continues into 
adulthood, implying that CHD7 deficiency in the SVZ neural stem cell niche may 
play a role in the olfaction.  In order to study the role of CHD7 in SVZ neural stem 
cell function, I generated conditional Chd7 knockout mice using a Chd7flox allele 
and ubiquitous or neural stem cell-specific Cre recombinases.  In adult mice, 
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Chd7 deficiency leads to decreased SVZ proliferation, ventriculomegaly, fewer 
neuroblasts and mature OB interneurons, and increased glial cells.  Conditional 
adult and perinatal knockout mice display defects in proliferation, self-renewal 
and neuronal differentiation which can be rescued by modulation of retinoic acid 
signaling.  By chromatin immunoprecipitation, CHD7 binds to the promoters of 
retinoic acid receptors and pro-neural genes in neural stem cells.  Additionally, 
microarray analysis of SVZ gene expression from control and Chd7 conditional 
knockout mice shows that neuronal differentiation, migration and maturation 
genes are down-regulated upon loss of Chd7.  Together, these data suggest that 
CHD7 plays a critical role in the development and maintenance of the SVZ neural 
stem cell niche.  My research has helped to identify molecular mechanisms of 
CHD7 function in neural stem cells could improve diagnostic and therapeutic 











The development and maintenance of the mammalian brain requires 
precise coordination of responses to external signaling events and cell type-
specific gene expression.  If the delicate balance of transcription factor and 
epigenetic modifier function and requisite gene expression changes is disturbed, 
aberrant brain development and maintenance can result in myriad neurological, 
cognitive and sensory deficits that can severely impact quality of life.  The neural 
stem cell niche in the subventricular zone (SVZ) of the lateral ventricles is of 
particular importance in brain development due to its role in populating the 
cerebral cortex and olfactory bulbs (OB) with neurons (Lois et al. 1993; Davis et 
al. 1994).  Interestingly, it is hypothesized that the expansion of the SVZ and its 
neural stem and progenitor cell pools accounts for the markedly more complex 
and neuron-rich cerebral cortex observed in humans compared to other animals 
(Kriegstein et al. 2006).  Throughout brain development and maturation, the SVZ 
plays a number of different neurogenic roles that change in an age-dependent 
manner and continues to be proliferative into adulthood (Doetsch et al. 1999).   
 
SVZ neural stem cell function during corticogenesis 
 The mammalian forebrain is created from the closing of the neural tube 
which traps presumptive cerebrospinal fluid in spaces called the lateral ventricles 
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(Kriegstein et al. 2006).  Neuroepithelial cells, resembling radial glia with a single 
basal fiber contacting the pia, line the ventricles and begin to express neural 
stem cell markers such as Nestin and Sox2 (Rakic 1978; Choi 1988; Ferri et al. 
2004; Gotz et al. 2005).  These neural stem cells form a layer of proliferative cells 
which will populate the cortex with neurons through a series of symmetric and 
asymmetric cell divisions termed corticogenesis (Noctor et al. 2001).   
In the mouse brain, corticogenesis begins at embryonic day 10 and 
transitions away from cortical neurogenesis by embryonic day 16 (Wichterle et al. 
2001).  In the early phases of corticogenesis, neural stem cells in the ventricular 
zone undergo symmetric cell divisions by vertical cleavage in order to expand the 
stem cell pool (Fig. 1.1A) (Smart 1973; Chenn et al. 1995).  Following this clonal 
expansion, neural stem cells begin to divide in both symmetric and asymmetric 
patterns (Noctor et al. 2004; Shitamukai et al. 2011).  Symmetric divisions 
continue to produce two neural stem cells, while asymmetric divisions by 
horizontal cleavage produce a neural stem cell and a transit amplifying progenitor 
cell (Noctor et al. 2008).  Most neural progenitor cells express Ascl1, Pax6 and 
Tbr2 while rapidly dividing to exponentially amplify the pool of progenitor cells, 
thereby creating a new layer of cells in the presumptive cortex called the 
subventricular zone (Fig. 1.2) (Parras et al. 2004; Kim et al. 2007; Brill et al. 
2009).  Progenitor cells in the SVZ also divide asymmetrically to produce a 
progenitor cell and a Neurod1, Dcx and Tbr1-expressing neuroblast, which 
migrates radially, matures and integrates to form the layers of the cortex (Brill et 
al. 2009; Roybon et al. 2009).  Interestingly, there are distinct SVZ progenitor 
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zones surrounding the ventricles that produce a wide variety of neurons 
depending on spatial location.  Progenitor cells produce different types of 
neurons depending on their expression of various pro-neural and pro-glial genes 
including: Ngn2, Ascl1, Pax6, Emx1, Gsh2, Nkx2.1, Dlx1 and Olig2 (Fig. 1.2) 
(Anderson et al. 1999; Sussel et al. 1999; Cecchi et al. 2000; Stoykova et al. 
2000; Hevner et al. 2001; Stuhmer et al. 2002). For example, neurons created in 
the lateral ganglionic eminence (LGE) along the lateral wall of the lateral 
ventricles preferentially express Gsh2 and Pax6 and create both dopaminergic 
tyrosine hydroxylase+ and GABAergic calbindin+ neurons (Marin et al. 2001).  In 
contrast, progenitor cells in the medial ganglionic eminence (MGE), a region 
ventromedial to the LGE, preferentially expresses Nkx2.1 and produce only 
GABAergic calbindin+ and calretinin+ neurons (Marin et al. 2001).   
 
SVZ neural stem cell function during olfactory bulb neurogenesis 
As corticogenesis wanes around embryonic day 15 in mice, the SVZ 
begins to thin and the lateral ventricles reduce in volume, while keeping the 
neurogenic stem cell niches of the LGE and MGE intact along the dorsoventral 
axis of the ventricle (Fig. 1.1B) (Wichterle et al. 2001).  The SVZ stops producing 
radially migratory neurons for the cortex and begins to create neurons that move 
along the rostral migratory stream (RMS), a bundle of neuroblasts and immature 
neurons ensheathed in blood vessels and supporting glia, that tangentially 
migrate into the olfactory bulb (Fig. 1.1D) (Lois et al. 1996; Lledo et al. 2008).  As 
the neuroblasts begin to arrive in the OB, they transition into immature olfactory 
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bulb interneurons, radially migrate to the granule cell and glomerular layers of the 
OB, and begin to express markers of mature dopaminergic and GABAergic OB 
interneurons such as tyrosine hydroxylase, calbindin and calretinin (Kosaka et al. 
1995; Belluzzi et al. 2003; Carleton et al. 2003).   The olfactory bulb is 
responsible for processing sensory inputs from olfactory sensory neurons in the 
nasal epithelium (Lledo et al. 2005).  Hypoplasia or aplasia of the olfactory bulbs 
results in a condition called arrhinencephaly, which can impair the sense of smell 
and lead to hyposmia or anosmia.  Additionally, the late embryonic and postnatal 
SVZ produces GLAST+, O4+ and PDGFR-α+ oligodendrocyte progenitor cells 
which migrate into the overlying white matter and striatum and differentiate into 
mature GFAP+ glia (Alvarez-Buylla et al. 2001).  This progression of intricate cell 
divisions and differentiation events from neural stem cell to mature neuron is vital 
for the proper formation of the mammalian cortex. 
The process of OB neurogenesis in the SVZ is not unique to the late 
embryonic and early postnatal time points; rather, this process continues 
throughout adulthood (Fig. 1.1C) (Alvarez-Buylla et al. 2004).  Adult-born OB 
interneurons are vital for the creation of olfactory memory and odor discrimination 
(Wachowiak et al. 2006).  Interestingly, the precise molecular programs which 
govern SVZ neurogenesis, as discussed above, are largely unchanged from 
corticogenesis to adult olfactory bulb neurogenesis (Alvarez-Buylla et al. 2001; 
Lledo et al. 2006; Lledo et al. 2008; Hsieh 2012).  Consistent with the former 
identity of the embryonic LGE and MGE, different classes of olfactory bulb 
interneurons are born from different regions along the dorsoventral axis of the 
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late embryonic and postnatal SVZ, and migrate tangentially along the RMS into 
the OB instead of radially into the cortex (Merkle et al. 2007; Young et al. 2007).  
Two major factors play a role in the precise regulation of SVZ neurogenesis 
throughout development and maintenance: extracellular morphogens and 
epigenetic modifiers.  These will be discussed separately in the following 
sections.  
 
Signaling pathways in SVZ neurogenesis 
Wnt signaling 
 The Wnt signaling pathway has been demonstrated to regulate a variety of 
stem cell populations including those in the skin, blood, muscle and intestinal 
endothelium, and to promote maintenance of pluripotency in embryonic stem 
cells (Ciani et al. 2005).  In the embryonic forebrain, Wnt serves to promote a 
cortical identity for the dorsal telencephalon (Wilson et al. 2000; Backman et al. 
2005). Beginning at E11 in the SVZ, Wnts are responsible for maintaining an 
actively proliferating stem cell pool that will populate the cortex with neurons 
(Chenn et al. 2002; Sato et al. 2004; Hirabayashi et al. 2005).  During mid to late 
corticogenesis, Wnt signaling through β-catenin stimulates the expression of 
Neurod1, Ngn1 and Ngn2, thereby promoting neuronal differentiation 
(Hirabayashi et al. 2004).  Midway through corticogenesis at approximately 
embryonic day 13, Wnt signaling switches from promoting stem cell self-renewal 
and proliferation to stimulating neuronal differentiation; this switch is positively 
influenced by the presence of fibroblast growth factor 2 (FGF2) (Israsena et al. 
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2004).  This interaction between Wnt and growth factor signaling demonstrates 
the intricacy of the spatiotemporal regulation of the developing and adult brain. 
 
Growth Factor signaling 
 In the SVZ, several families of growth factors play important roles in the 
maintenance of neural stem cell identity through activation of receptor tyrosine 
kinases and downstream MAP kinase activity (Mason 2007).  Intraventricular 
infusion of FGF2 or epidermal growth factor (EGF) has shown that these growth 
factors are required for maintenance of the stem cell state by promoting neural 
stem cell self-renewal and proliferation while inhibiting the formation of neural 
progenitor cells and neuroblasts (Kuhn et al. 1997; Jin et al. 2003; Marshall et al. 
2003; Guillemot et al. 2011).  Additionally, EGF has been shown to promote 
neural stem cells to exclusively produce oligodendrocyte precursors at the 
expense of neural progenitor cells in the SVZ (Burrows et al. 1997; Morrow et al. 
2001).  Neurosphere assays, a test for the self-renewal, proliferation and 
differentiation capacity of neural stem cell populations, use a combination of FGF 
and EGF in the growth medium to maintain neurospheres in a self-renewing state 
(Reynolds et al. 1992; Pastrana et al. 2011).  The growth factor cocktail is 
removed from the medium to promote differentiation of neurosphere cells into 
neurons, glia and oligodendrocytes, thus demonstrating the ability of FGF and 
EGF to maintain the neural stem cell population (Pastrana et al. 2011).  
Similar to EGF, platelet derived growth factor (PDGF) and its associated 
receptor PDGFRα promote the oligodendrocytic fate of SVZ neural stem cells 
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and neurosphere self-renewal in vitro (Williams et al. 1997; Calver et al. 1998).  
In adult mouse SVZ, reduced PDGF signaling results in decreased stem cell self-
renewal, increased apoptosis and hydrocephalus (Carter et al. 2012).  
Interestingly, vascular endothelial growth factor (VEGF) stimulates the 
development of and maintains the vasculature that is necessary for the SVZ and 
RMS to receive signaling molecules and metabolites (Bovetti et al. 2007; 
Bozoyan et al. 2012).  These various growth factor families are required for the 
proper development and function of the SVZ neural stem cell niche beginning 
during corticogenesis and continuing throughout life. 
 
Hedgehog signaling 
 The hedgehog signaling pathway functions through the binding of a 
soluble hedgehog ligand to a heterodimeric receptor consisting of the inhibitory 
Patched subunit and the downstream activator subunit Smoothened (Ruiz i 
Altaba et al. 2002; Fuccillo et al. 2006).  Upon hedgehog ligand binding, Patched 
releases Smoothened and Smoothened activates the Gli affector proteins which 
promote gene expression (Ruiz i Altaba et al. 2002; Fuccillo et al. 2006).  
Generally, hedgehog signaling gradients oppose Wnt signaling gradients, 
thereby creating ventral and dorsal boundaries (Kessaris et al. 2001).  
Throughout life, hedgehog signaling is necessary for proper maintenance of the 
SVZ neural stem cell niche and preserves the dorsoventral patterning of the SVZ 
to produce various types of olfactory bulb interneurons (Lledo et al. 2008; Ihrie et 
al. 2011).  Mice with conditional loss of hedgehog signaling in SVZ neural stem 
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cells leads to a significant reduction in calbindin+ OB interneurons, 
demonstrating the requirement for hedgehog signaling in the ventral SVZ (Ihrie et 
al. 2011). 
 
Retinoic Acid signaling 
   Retinoic acid signaling is a highly complex process that begins by 
translocation of retinol into the cytoplasm where it is processed by retinol 
dehydrogenase to produce retinaldehyde (Fig. 1.3) (Maden 2002; Maden 2007; 
Niederreither et al. 2008).  Retinaldehyde is further processed to the final form of 
retinoic acid (RA) by retinaldehyde dehydrogenases (Maden 2002; Maden 2007; 
Niederreither et al. 2008).  From this point, RA can function in an autocrine 
manner, by binding cellular retinoic acid binding proteins (CRABP) and 
translocating to the nucleus of the cell, or RA can freely diffuse out of the cell and 
enter an adjacent cell in a paracrine manner before binding CRABP and 
translocating into the nucleus (Maden 2007).  In both cases, RA binds a 
heterodimer of a single retinoic acid receptor (RAR) and a single retinoid X 
receptor (RXR) which are bound to consensus retinoic acid response elements 
(RARE) (Niederreither et al. 2008).  Upon activation of the heterodimer by RA 
binding, target gene expression is activated (Niederreither et al. 2008).   
 During brain development, RA signaling plays an intermediate role by 
interacting with both ventral hedgehog signaling and dorsal Wnt signaling (Rhinn 
et al. 2012).    In contrast to growth factor signaling, which generally regulates 
maintenance of neural stem cells and their differentiation into oligodendrocyte 
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progenitor cells, RA signaling functions to induce neurogenesis by upregulation 
of pro-neural genes (Thompson Haskell et al. 2002).  RA signaling is particularly 
important for the differentiation of GABAergic interneurons of the cortex and 
olfactory bulbs (Anchan et al. 1997).  Neurosphere assays have confirmed RA 
function in vitro by demonstrating an increase in proliferation and neuronal 
differentiation upon treatment with RA, while reduced RA signaling produces the 
opposite effect (Haskell et al. 2005; Wang et al. 2005).  In conjunction with Wnt, 
growth factor and hedgehog signaling, retinoic acid is necessary for the proper 
timing of SVZ neural stem cell development and the cell fate and maturation of its 
pro-neuronal progeny. 
 
Epigenetic regulation of SVZ neurogenesis 
 Epigenetics is a broad term encompassing any mechanism by which gene 
expression can be altered without a change in genomic DNA sequence.  
Epigenetic regulation occurs by a variety of mechanisms including: DNA 
methylation, regulatory non-coding RNA, covalent histone modifications and 
ATP-dependent chromatin remodeling.  This section will review the roles of 
histone modifications and ATP-dependent chromatin remodeling in determination 
of cell fate and differentiation decisions within stem cells and their progeny, 






Histone modifying enzymes 
 Promoter and enhancer elements of pro-neural genes can be maintained 
in one of three states: inactive, poised and active (Fig. 1.4).  Inactive genetic 
elements display histone modifications that are indicative of repressed chromatin 
including H3K27me3, the defining modification of the Polycomb Repressive 
Complex, and H3K9me3 (Simon et al. 2009).  Active genetic elements favor 
histone modifications such as mono-, di- and trimethylation H3K4, marks placed 
by the Trithorax group member MLL1, and a variety of acetylation events 
including H3K27ac (Azuara et al. 2006).  Polycomb group member Bmi-1 also 
plays an integral role in SVZ neural stem cell self-renewal and proliferation 
(Molofsky et al. 2003).  When Bmi-1 is deleted in mice, there is a drastic 
reduction in neurons due to the reduced size of the neural stem cell pool causing 
a number of brain abnormalities (Molofsky et al. 2005).  Thus, the genome of 
neural stem cells is tightly regulated by specific histone modifications that can 
promote or repress gene expression necessary for proper stem cell function. 
While it is quite common for genes to be completely active or inactive in 
fully differentiated cells, the chromatin environment in stem and progenitor cells 
tends to be more open (euchromatic) and poised for either repression or 
activation (Azuara et al. 2006; Bernstein et al. 2006).  Poised enhancers and 
promoters typically display both active and repressive marks (Zhou et al. 2011).  
For example, a poised enhancer element might contain the activating H3K4me1 
mark and the repressive H3K9me3 mark, while a poised promoter would contain 
the activating H3K4me3 modification and the repressive H3K27me3 mark.  In the 
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SVZ, the pro-neural genes Ascl1 and Dlx2, whose expression is indicative of 
neural differentiation, have high levels of the activating mark H3K4me3 (Lim et al. 
2009).  In mice, loss of the Trithorax group H3K4 methyltransferase Mll1 in the 
SVZ does not affect neural stem cell survival, proliferation or gliogenic 
differentiation, but severely inhibits neuronal differentiation (Lim et al. 2009).  In 
the wild type mouse SVZ, MLL1 binds to the promoters of Ascl1 and Dlx2, co-
localizes with H3K4me3 and stimulates their expression.  In Mll1 null mice, the 
Dlx2 promoter switches from an active to a poised status by maintaining the 
H3K4me3 mark, and gaining the repressive H3K27me3 modification. These 
epigenetic modifications and reduction in Dlx2 expression are an example of how 
chromatin states strongly influence gene expression in developing neural stem 
cells of the SVZ. 
 
ATP-dependent chromatin remodeling enzymes 
 Chromatin remodeling enzymes read the histone modifications through 
specialized protein domains and influence gene expression by disrupting DNA-
histone interactions, sliding nucleosomes along the DNA strand to make room for 
transcription factors, or translocating the nucleosome core particle to another 
DNA strand (Smith et al. 2005).  There are three major superfamilies of ATP-
dependent chromatin remodeling enzymes in eukaryotic organisms (SWI/SNF, 
ISWI and CHD), each of which has a characteristic histone interaction domain 
(de la Serna et al. 2006).  Here, I will discuss the Chromodomain Helicase DNA-
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binding (CHD) superfamily of chromatin remodelers focusing on CHD7, the only 
family member that has a human syndrome associated with its dysfunction. 
 
Structure and function of the CHD superfamily 
 The CHD family of ATP-dependent chromatin remodeling enzymes 
consists of nine proteins divided into three subfamilies based on domain 
homology (Fig. 1.5).  All CHD proteins contain two common domains, two 
tandem chromodomains and a SNF2-like helicase-ATPase (Hall et al. 2007; 
Layman et al. 2010).  Chromodomains were originally characterized in 
Drosophila heterochromatin protein 1 (HP1) which uses its chromodomain to 
bind nucleosomes and contribute to promotion of closed chromatin states 
(heterochromatin) at homeotic genes associated with Drosophila development 
(Pearce et al. 1992; Wreggett et al. 1994; Ball et al. 1997).  The primary function 
of chromodomains is to facilitate protein-protein interactions with methylated 
histone residues as illustrated by the binding affinity of HP1 to the repressive 
histone modification H3K9me3 leading to formation of heterochromatin (Ball et al. 
1997; Brehm et al. 1999; Pray-Grant et al. 2005).  Conversely, CHD proteins 
contain a unique variant of the chromodomain which contains a methyl-binding 
cage which facilitates interactions with H3K4 (Flanagan et al. 2005; Pray-Grant et 
al. 2005).  While there exists a contrast in chromodomain function dependent on 
the protein family, these methyl-histone binding protein domains are essential for 




The helicase-ATPase domains of CHD proteins are highly similar to those 
observed in the SWI/SNF superfamily of ATP-dependent chromatin remodeling 
enzymes (Hirschhorn et al. 1992; Hall et al. 2007).  Originally discovered  in the 
SWI2/SNF2 protein, the helicase-ATPase domain functions as a bi-lobed motor 
by providing the chemical energy to cause mechanical disruption of DNA-histone 
contacts leading to core histone sliding down a DNA template or core histone 
evacuation and deposition on another DNA strand (Winston et al. 1992; Peterson 
et al. 1994; Pazin et al. 1997; Becker et al. 2002).   
Additionally, the CHD subfamilies are delineated by the presence of 
subfamily-specific protein domains.  CHD1 and CHD2 contain DNA-binding 
domains, which have been shown to be similar in function to SANT domains 
present in CHD6-9 (Ryan et al. 2011). The SANT domain confers non-specific 
DNA binding, particularly to linker DNA between nucleosomes (Aasland et al. 
1996; Schuster et al. 2002; Boyer et al. 2004).  In recombinant CHD1 with 
deletion of the SANT domain, CHD1 loses the ability to bind both DNA and 
nucleosomes demonstrating that the SANT domain is critical for nucleosomal 
targeting by the chromatin remodeler (Ryan et al. 2011).  CHD3 and CHD4 lack a 
DNA-binding domain, but contain tandem plant homeo domains (PHD) (Bienz 
2006).  PHD domains are zinc finger motifs that facilitate interactions with 
methylated histone residues and protein co-factors including between CHD3/4 
and histone deacetylase 1 (HDAC1) which is part of the potent negative 
transcriptional regulation complex called NuRD (nucleosome-remodeling 
deactylase complex) (Xue et al. 1998).  CHD7-9 also contain tandem BRK 
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domains that interact with Drosophila Brahma and BRG1, but currently have no 
known function (Daubresse et al. 1999).  Regardless of overall protein domain 
structure, the function of CHD superfamily proteins is intimately tied to regulation 
of gene expression through modulation of nucleosomes.  One of the emerging 
trends consistent across the entire CHD family is the role of CHD proteins in the 
maintenance of stem cell populations and directing the cell fate decisions of their 
progeny.  
 
CHD family members and their functions in stem cells 
CHD proteins and embryonic stem cells 
 Embryonic stem cells are a self-renewing and pluripotent cell population 
from which the majority of tissues are derived.  These cells are viewed as a blank 
slate with an open chromatin environment, and progressively become more 
differentiated by activating or repressing various genetic pathways to become 
neural, hematopoietic and other lineage-specific cells.  CHD1 has been shown to 
regulate the function of embryonic stem cells by maintaining open chromatin 
(Gaspar-Maia et al. 2009).  CHD1 specifically binds to tracts of the active gene 
marker tri-methylated histone H3 at the residue lysine 4 (H3K4me3) and 
excludes the repressive marker H3K27me3 (Gaspar-Maia et al. 2009).  
Furthermore, the Mediator complex, a multi-protein complex responsible for pre-
initiation of gene transcription, binds to CHD1 and recruits it to actively expressed 
genes (Lin et al. 2011).  When CHD1 is deleted in embryonic stem cells, 
chromatin condenses to form heterochromatin and pluripotent differentiation is 
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impaired, potentially, due to the promotion of ectodermal lineage gene 
expression at the expense of endodermal lineage gene expression (Gaspar-Maia 
et al. 2009).  Additionally, induction of CHD1 expression is required for efficient 
reprograming of mature fibroblasts into induced pluripotent stem cells (iPS) 
(Gaspar-Maia et al. 2009).  These studies show that CHD family proteins are vital 
for maintaining pluripotency in embryonic stem cells and may play an important 
role in the development of personalized medicine through iPS cell therapies. 
 
CHD proteins and mesenchymal stem cells 
 Mesenchymal stem cells are multipotent mesoderm-derived cells that give 
rise to myoblasts (muscle), adipocytes (fat), osteoblasts (bone) and chondrocytes 
(cartilage) (Ralston et al. 2006; Chamberlain et al. 2007; Uccelli et al. 2008).  The 
differentiation of mesenchymal stem cells into four distinct lineages has been 
shown to be regulated by several CHD family proteins.  Induction of myogenic 
cell fates has been shown to require the recruitment of a chromatin destabilizing 
histone variant histone H3.3 by CHD2 to muscle differentiation genes, which 
facilitates binding and gene activation by the transcription factor MyoD (Harada 
et al. 2012).  Additionally, CHD9, also known as chromatin-related mesenchymal 
modulator (CReMM), binds to and promotes the expression of osteocalcin 
(Bglap3), one of the major genes responsible for promoting bone development 
(Shur et al. 2005; Shur et al. 2006).  These findings emphasize the diverse and 
potentially non-redundant functions of CHD family proteins in mesenchymal cell 
fate decisions, even within the same stem cell type. 
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CHD proteins and hematopoietic stem cells 
  The vast diversity of myeloid and lymphoid cell types present in blood are 
derived from a common hematopoietic stem cells (Kondo et al. 2003; Ugarte et 
al. 2013).  Hematopoietic stem cells reside largely in the bone marrow and can 
adopt one of two potential lineages: myeloid and lymphoid (Kondo et al. 2003).  
Myeloid lineage cells give rise to red blood cells, platelet-producing 
megakaryocytes and granulocyte immune cells (Bovetti et al. 2007).  Lymphoid 
lineage cells give rise to natural killer, T- and B-cells which play important roles in 
cellular immunity (Bovetti et al. 2007).  CHD4, also known as Mi-2β, is a 
Nucleosome Remodeling Deacetylase complex (NuRD) component that has 
been shown to regulate the self-renewal of hematopoietic stem cells (Yoshida et 
al. 2008).  Additionally, loss of Chd4 in bone marrow leads to an abundance of 
erythroid progenitors and red blood cells and loss of the lymphoid and remaining 
myeloid lineage cell types (Yoshida et al. 2008).  Further examination of CHD4 
activity in the regulation of hematopoietic stem cells may provide novel insights 
into mechanisms of human diseases such as cancers affecting lymphoid lineage 
cells including leukemia and lymphoma. 
 
CHD proteins and neural stem cells 
Neural stem cells play a vital role in the development and maintenance of 
the central nervous system and in sensory organs by producing neurons and 
supporting cells such as glia and oligodendrocytes.  CHD4 and CHD5 have been 
demonstrated to play important roles in the function and differentiation of neural 
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stem cell niches in the subventricular zone of the forebrain and dentate gyrus of 
the hippocampus through cooperation with major epigenetic modifiers, 
transcription factors and signaling pathways.  During cortical neurogenesis, 
CHD4 is expressed in murine SVZ neural progenitor cells and interacts with the 
Polycomb Repressive Complex 2 (PRC2), specifically with the H3K27 
methyltransferase enzyme Ezh2 (Cao et al. 2002; Sparmann et al. 2013).  The 
CHD4/PRC2 complex directly binds to the promoter of the Glial Fibrillar Acidic 
Protein gene (Gfap), represses its expression and prevents glial differentiation 
(Sparmann et al. 2013).  Through inhibition of the Gfap locus, CHD4 and PRC2 
promote neuronal differentiation during the neurogenic period between E11-E18 
in mice (Sparmann et al. 2013).   
Similar to CHD4, CHD5 also interacts with the PRC2 complex and 
specifically associates with the repressive histone modification H3K27me3 in 
neural stem cells (Egan et al. 2013).  CHD5 is highly expressed in neural 
progenitor and neuroblast cells of the SVZ and subgranular zone (SGZ) of the 
hippocampus, which produces neurons that are important for learning and 
memory (Egan et al. 2013).  Reduced Chd5 expression in the developing cortex 
leads to a significant loss of migratory neuroblasts.  Additionally, microarray and 
gene ontology analysis of Chd5-deficient neural stem cells showed 
downregulation of genes responsible for neuronal migration and maturation 
(Egan et al. 2013).  Taken together, these studies demonstrate that CHD4 and 
CHD5 play an important role in the inhibition of glial differentiation during key 
neurogenic phases of mammalian brain development. 
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CHD7 and stem cells 
 Chd7 has been implicated in several stem cell populations and appears to 
be critical for regulating cell fate decisions through modulation of signaling and 
epigenetic pathways.  Chd7 is highly expressed in embryonic stem cells, where it 
appears to function similar to CHD1 by associating with signals of active gene 
expression and open chromatin at enhancer elements of critical stem cell 
pluripotency genes including Sox2, Oct4 and Nanog (Zentner et al. 2011).  CHD7 
preferentially binds active (H3K4me1+, H3K27ac+) and poised (H3K4me1+, 
H3K27me3+) enhancer elements at ectodermal lineage genes in embryonic stem 
cells (Zentner et al. 2011). This finding is particularly intriguing due to the 
contribution of ectodermal lineages to tissues affected in CHARGE syndrome 
including the brain, retina and neural crest-derived structures in the heart and 
craniofacial structures.  Similar to MLL1, co-localization of CHD7 with poised 
genetic elements presents a paradigm where CHD7 may play a role in 
recruitment of transcription factor, histone modifier and/or chromatin remodeling 
complexes in a cell type-specific manner to promote the activation or repression 
of certain classes of genes by resolution of the poised status. 
 Studies in mesenchymal stem cells have shown that CHD7 is critical for 
Wnt-mediated repression of PPAR-γ through recruitment of a complex containing 
CHD7, NLK and SETDB1 (an H3K9 methyltransferase), thus leading to an 
osteoblast fate (Takada et al. 2007).  Notably, upon reduction of CHD7, PPAR-γ 
is free to perform its function as a potent activator of adipocyte lineage genes, 
demonstrating a clear role for CHD7 in cell fate decisions (Takada et al. 2007).  
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In neural stem cells, co-immunoprecipitation and chromatin immunoprecipitation 
studies have shown that CHD7 physically interacts with SOX2 at genes that are 
associated with human diseases including Alagille syndrome (JAG1, a Notch 
signaling ligand), Feingold syndrome (MYCN, a bHLH transcription factor) and 
Pallister-Hall syndrome (GLI3, a mediator of Sonic hedgehog signaling) (Engelen 
et al. 2011).  Many phenotypes that are present in these syndromes are also 
seen in CHARGE including genital abnormalities (Pallister-Hall and SOX2 
deficiency), tracheoesophageal defects (Alagille, Feingold and SOX2 deficiency), 
pituitary defects (Pallister-Hall and SOX2 deficiency) and semicircular canal 
hypoplasia (Alagille) (Fig. 1.6).  These observations demonstrate that CHD7 
activity is important for a variety of stem cell differentiation and cell fate 
decisions.  
Recently, CHD7 was shown to be expressed in the subgranular zone 
(SGZ) of the hippocampus and the SVZ of adult mice where it co-localizes with 
markers of neural stem cells (GFAP), neural progenitor cells (Ascl1) and 
neuroblasts (DCX) (Feng et al. 2013).  Longitudinal studies in temporally induced 
conditional knockout of Chd7 in adult SVZ neural stem cells show that Chd7-
deficiency leads to a reduction in mature dopaminergic and GABAergic olfactory 
bulb interneurons and reduced expression of pro-neural genes Sox4 and Sox11 
(Feng et al. 2013).  In the SGZ of the hippocampus, conditional knockout of Chd7 
also leads to a reduction in neurogenesis, which can be rescued through 
exercise (Feng et al. 2013).  These data provide additional evidence that CHD7 
is critical for stem cell function in a variety of tissues. 
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CHD7 and CHARGE syndrome 
 CHARGE syndrome, a multiple congenital anomaly disorder that occurs in 
approximately 1 in 10,000 births, is characterized by Coloboma of the eye, Heart 
defects, Atresia of the choanae, Retardation of growth and development, Genital 
and Ear abnormalities (Pagon et al. 1981; Issekutz et al. 2005).  Heterozygous 
mutations in CHD7 are present in over 90% of individuals with CHARGE 
syndrome (Vissers et al. 2004; Bergman et al. 2011; Janssen et al. 2012).  
Despite identification of CHD7 mutations as the etiology of most CHARGE cases, 
there are no definitive genotype/phenotype correlations, likely due to the 
tremendous diversity of CHD7 nonsense, missense, deletion and truncation 
mutations and the variable expressivity of CHARGE features (Janssen et al. 
2012).  Biochemical assays with recombinant CHD7 protein have determined 
that CHD7 is an ATP-dependent chromatin remodeling enzyme capable of 
modulating DNA-histone interactions (Bouazoune et al. 2012).  Interestingly, 
when point mutations observed in CHARGE individuals are introduced into 
recombinant CHD7, its enzymatic activity is reduced in a mutation-specific 
manner (Bouazoune et al. 2012). 
CHD7 haploinsufficiency causes dysfunction in sensory processes leading 
to impaired hearing, vision, balance, and olfaction in CHARGE individuals.  In 
order to more fully understand the role of CHD7 in development and its impact on 
sensory processes, mouse models have been created.  A Chd7 gene trap null 
allele was generated in our lab through insertion of the lacZ reporter into the 
Chd7 allele, creating a functionally null allele with β-galactosidase reporter 
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activity (Hurd et al. 2007).  Interestingly, Chd7 null embryos do not survive past 
embryonic day 10.5, presumably from cardiovascular defects, while Chd7 
heterozygous mice display many of the same defects observed in CHARGE 
(Hurd et al. 2007). 
 Chd7 is widely expressed in the embryonic mouse, most notably in 
tissues affected in CHARGE syndrome including the heart, inner ear, eye, 
olfactory epithelium and brain (Hurd et al. 2007; Layman et al. 2010).  In each 
organ thus far analyzed, Chd7 expression has been predictive of tissue or 
cellular defects in mutant mice.  In the inner ear, Chd7 heterozygous mice 
display hypoplasia or aplasia of the lateral and posterior semicircular canals and 
innervation defects of the vestibular sensory epithelium (Adams et al. 2007; Hurd 
et al. 2010).  Conditional knockout of Chd7 using a floxed Chd7 allele causes 
complete aplasia of vestibular and cochlear structures, reductions in FGF 
signaling leading to decreased proliferation and reduced expression of pro-neural 
genes such as Ngn1 and Neurod1 (Hurd et al. 2010).  These data imply that 
CHD7 may function in brain neural stem cells as it does sensory tissues, through 
regulation of similar signaling pathways and activation of pro-neural gene 
expression.  
Hyposmia and anosmia, reduction or loss of the sense of smell, are two of 
the most highly penetrant phenotypes observed in CHARGE individuals.  
Olfactory deficits are commonly accompanied by hypoplasia or aplasia of the 
olfactory bulbs in the brain (Pinto et al. 2005; Layman et al. 2009; Bergman et al. 
2011; Legendre et al. 2012).  Chd7 heterozygous mice display complete 
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anosmia, lack of odor discrimination, and olfactory bulb hypoplasia (Layman et 
al. 2009).  Chd7 is expressed in olfactory epithelium neural stem and progenitor 
cells as demonstrated by co-localization with Sox2, Ascl1 and Neurod1 (Layman 
et al. 2009).  Loss of Chd7 correlates with a marked decrease in olfactory 
epithelium proliferation, a subsequent loss of innervation, and an inability to 
recover from damage (Layman et al. 2009).  Interestingly, Chd7 heterozygous 
mice show decreased dopaminergic tyrosine hydroxylase+ interneurons in the 
olfactory bulb, which could be due to lack of efferent signals from the olfactory 
epithelium or a defect in neurogenesis from the SVZ neural stem cell niche 
(Layman et al. 2009).   
 
Novel insights into CHD7 regulation of SVZ neural stem cells 
 Neural stem cells play a vital role in the development and maintenance of 
the central nervous system and in sensory organs by producing neurons and 
supporting cells such as glia and oligodendrocytes.  Dysregulation of the 
transcriptional programs of neural stem cells and their progeny (neurons, glia and 
oligodendrocytes) can cause neurological disease and, in the case of CHD7 
haploinsufficiency, lead to the severe defects in multiple neural-derived tissues 
observed in CHARGE syndrome.  Thus, understanding the molecular and 
regulatory mechanisms of CHD7 function in neural stem cells is of vital 
importance to developing diagnostic and therapeutic techniques, and may 
improve the quality of life for CHARGE individuals.  In this dissertation, I have 
focused my analysis on the function of Chd7 in the olfactory bulb and SVZ neural 
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stem cell population in the embryonic, early postnatal and adult mouse in order to 
identify mechanisms that may help explain some of the neurological defects that 
are hallmarks of CHARGE syndrome.  
 In Chapter 2, I thoroughly analyzed the function of CHD7 in the adult and 
perinatal SVZ.  In adult mice, I found that loss of Chd7 led to fewer olfactory bulb 
interneurons, impaired neural stem cell function and a potential switch from a 
neuronal fate to a glial fate of migrating neuroblasts.  Chd7-deficiency in perinatal 
mice caused defects neural stem cell self-renewal, proliferation and neuronal 
differentiation which could be rescued with modulation of retinoic acid signaling.  
These studies suggest that Chd7 plays an important role in SVZ neural stem cell 
function throughout life and loss of Chd7 in the SVZ partially contributes to 
olfactory bulb and olfaction deficits. 
 In Chapter 3, I performed genome-wide analysis of the SVZ in Chd7-
deficient mice and further investigated the link between CHD7 and retinoic acid 
signaling.  Upon loss of Chd7, microarray analysis of SVZ gene expression 
showed reduction in genes important for learning, memory, cognition, neuronal 
differentiation, migration and maturation.  Interestingly, expression of genes 
encoding the retinoic acid receptors Rarb and Rxrg was down-regulated in the 
Chd7-deficient SVZ, consistent with data shown in Chapter 2.  Using P19 
embryonal carcinoma cells, I have shown that CHD7 directly binds retinoic acid 
receptors and knockdown of Chd7 led to impaired P19 cell growth and pro-neural 
gene expression.   
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 In Chapter 4, I investigated the role of CHD7 in the development of the 
mouse cerebral cortex.  CHD7 co-localized with neural stem and progenitor cell 
markers in the SVZ during corticogenesis.  Conditional knockout of Chd7 in 
neural stem cells showed no impairment of proliferation, self-renewal or 
differentiation.  These data imply that CHD7 is not required for proper neural 
stem cell function during corticogenesis, but leave the possibility for a role for 
CHD7 in neuroblasts migration and maturation.  Taken together, I have 
demonstrated an important role for CHD7 function in the developing and adult 
mouse SVZ neural stem cell niche, which may provide insights into sensory 




Figure 1.1: Morphogenesis of the mouse forebrain throughout development. 
(A) Schematic showing a coronal section of the forebrain at embryonic day 13.5 (E13.5) with 
neural stem and progenitor cells in the ventricular and subventricular zones (gray, VZ/SVZ) 
surrounding the lateral ventricles (black, LV), which produce neurons bound for the cortex (Ctx). 
(B) Schematic showing a coronal section of the forebrain at postnatal day 1 (P1) with a 
constricted SVZ that produces neurons bound for the olfactory bulb (OB). (C) Schematic showing 
a coronal section of the adult forebrain with an SVZ that is restricted to the lateral wall of the LV. 
(D) Schematic showing a sagittal section of the forebrain where neurons are born along the LV, 
migrate through the rostral migratory stream (RMS) and integrate into the OB. Other 





Figure 1.2: Lineage-specific markers of SVZ-derived cells. 
Nestin, GFAP and Sox2 are present in SVZ neural stem cells, which can self-renew to make 
another stem cell or produce a neural progenitor cell.  Neural progenitor cells continue to express 
Sox2, begin expression of pro-neural markers Ascl1 and Tbr2 and produce Neurod1- and DCX-
expressing neuroblasts.  As neuroblasts migrate through the RMS and into the OB, they begin to 
express Tbr1 in addition to DCX.  Upon reaching the proper OB layer, neurons express 
GABAergic (CALB and CALR) or dopaminergic (TH) markers, then mature and integrate into the 




Figure 1.3: Transcriptional regulation by retinoic acid signaling. 
Retinol traverses the cell membrane and is bound by cellular retinol binding protein (CRBP).  
Retinol dehydrogenases (RDH) metabolize retinol into retinaldehyde which is subsequently 
converted to retinoic acid (RA) by retinaldehyde dehydrogenases (RALDH). Cellular retinoic acid 
binding protein (CRABP) binds RA that has either freely diffused into the cell or produced 
intracellularly by RDH and RALDH from retinol and translocates RA into the nucleus.  RA binds 
retinoic acid receptor and retinoid X receptor heterodimers (RAR/RXR) that are associated with 
retinoic acid response elements (RARE) at RA target genes.  Upon RA binding, co-activators or 
co-repressors are recruited to the activated RAR/RXR complex which can recruit or block RNA 
polymerase II (Pol II), TATA binding protein (TBP) and TBP-associated factors (TAF).  Re-





Figure 1.4: Distinct histone modifications mark the status of promoter and enhancer elements. 
(A) Promoter elements can possess three sets of chromatin modifications that denote active 
(H3K4me3 and acetylation of histone H4), poised (H3K4me3 and H3K9me3) or inactive genes 
(H3K9me3 and H3K27me3). (B) Similar to promoters, enhancer elements can also contain 
histone modification indicative of active (H3K4me1 and K3K27ac), poised (H3K4me1 and 





Figure 1.5: Domain schematic of CHD superfamily members. 
The CHD superfamily is comprised of three subfamilies.  CHD1 and CHD2 comprise subfamily I 
and contain tandem chromodomains (purple), an ATPase-helicase domain (blue) and a loosely-
specific DNA-binding domain (orange).  Subfamily II is composed of CHD3 and CHD4 which lack 
the DNA-binding domain of subfamily I, but contain tandem PHD zinc finger domains (yellow).  
While CHD5 is considered a member of subfamily II, it only contains tandem chromodomains and 
an ATPase-helicase domain with no known additional structural motifs.  CHD6 through CHD9 
comprise subfamily III and have characteristic SANT (red) and tandem BRK domains (green) in 




Figure 1.6: The SOX2/CHD7 complex regulates genes involved in human syndromes. 
SOX2 and CHD7 form a complex in neural stem cells and bind pro-neural genes including: sonic 
hedgehog signaling genes (GLI2 and GLI3), a notch signaling gene (JAG1) and a basic helix-
loop-helix transcription factor gene (MYCN).  Genetic deficiency of CHD7 results in CHARGE 
syndrome which shares phenotypes with human syndromes associated with GLI2-deficiency, 
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CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner 




CHARGE syndrome is a multiple congenital anomaly disorder that leads 
to life-threatening birth defects such as choanal atresia and cardiac 
malformations as well as multiple sensory impairments that affect hearing, vision, 
olfaction, and balance.  CHARGE is caused by heterozygous mutations in CHD7, 
which encodes an ATP-dependent chromatin remodeling enzyme.  Identification 
of the mechanisms underlying neurological and sensory defects in CHARGE is a 
first step toward developing treatments for CHARGE individuals.  Here I used 
mouse models of Chd7-deficiency to explore the function of CHD7 in the 
development of the subventricular zone (SVZ) neural stem cell niche and inner 
ear, structures that are important for olfactory bulb neurogenesis and hearing and 
balance, respectively.  I found that loss of Chd7 results in cell-autonomous 
proliferative, neurogenic, and self-renewal defects in the perinatal and mature 
mouse SVZ stem cell niche.  Modulation of retinoic acid (RA) signaling prevented 
in vivo inner ear and in vitro neural stem cell defects caused by Chd7-deficiency.  
My findings demonstrate critical, cooperative roles for RA and CHD7 in SVZ 
neural stem cell function and inner ear development, suggesting that altered RA 




CHARGE syndrome is a multiple anomaly disorder occurring in 1:10,000 
live births and characterized by ear and heart defects, choanal atresia, 
retardation of growth and/or development, and delayed puberty (Pagon et al. 
1981; Issekutz et al. 2005).  In addition, olfactory bulb (OB) hypoplasia and 
hyposmia/anosmia are highly penetrant in CHARGE individuals; strikingly, 
arrhinencephaly and ventriculomegaly have been reported in CHARGE fetuses 
(Pinto et al. 2005; Layman et al. 2009; Bergman et al. 2011; Legendre et al. 
2012).  Heterozygous mutations in CHD7, which encodes an ATP-dependent 
chromatin remodeling enzyme, account for over 90% of CHARGE syndrome 
cases, yet no clear genotype-phenotype correlations have emerged (Vissers et 
al. 2004; Bergman et al. 2011; Janssen et al. 2012).  Beyond supportive 
treatments and surgical intervention, there are no curative therapies for 
CHARGE-related defects. 
 Mouse models of CHARGE syndrome recapitulate most phenotypes 
observed in humans, including inner ear defects (semicircular canal and cochlear 
hypoplasia/dysplasia), OB hypoplasia, and hyposmia/anosmia (Bosman et al. 
2005; Hurd et al. 2007; Layman et al. 2009; Bergman et al. 2010; Hurd et al. 
2010; Hurd et al. 2011; Hurd et al. 2012).  The underlying causes of inner ear 
defects and OB hypoplasia in Chd7-deficiency states are unknown, but there is 
evidence for disrupted neural stem cell proliferation in the otocyst and olfactory 
epithelium (Layman et al. 2009; Hurd et al. 2010).  In the olfactory system, OB 
interneurons (granule and periglomerular cells) arise from neural stem cells in the 
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subventricular zone (SVZ) of the lateral ventricles (LV), which give rise to 
neuroblasts that migrate through the rostral migratory stream (RMS) over a 2-3 
week period (Lledo et al. 2008).  SVZ-derived neuroblasts then terminally 
differentiate and integrate into the granule cell (GCL) and glomerular (GL) layers 
of the OB, where they mature into inhibitory interneurons that modulate mitral 
and tufted cells, which relay olfactory sensory signals to the olfactory cortex 
(Lledo et al. 2008).  In rodents, OB neurogenesis begins around embryonic day 
15 (E15) and continues throughout life (Luskin 1993; Wichterle et al. 2001).  
Thus, OB neurogenesis is an excellent system for studying CHD7 function in 
neural development and maintenance.   
Development and maintenance of the inner ear, SVZ, RMS, and OB are 
regulated in part by retinoic acid (RA) signaling (Anchan et al. 1997; Thompson 
Haskell et al. 2002; Romand et al. 2013).  Notably, treatment of SVZ neural stem 
cell cultures with RA promotes neurogenesis (Wang et al. 2005), whereas 
reduction or absence of RA signaling results in proliferative and neurogenic 
defects in both the adult and developing SVZ (Haskell et al. 2005).  Interestingly, 
deficiency in RA receptors or synthetic enzymes leads to phenotypes similar to 
those observed in CHARGE syndrome including eye, heart and brain 
abnormalities (Mark et al. 2009; Janssen et al. 2012).  Despite having highly 
similar developmental effects in mammalian tissues, potential interactions 
between CHD7 and RA signaling pathways have not been explored. 
 The highly penetrant OB hypoplasia/aplasia and olfaction deficits in 
CHARGE individuals and Chd7-deficient mice suggest that Chd7 may have a 
44 
 
role in the maintenance and differentiation of neural stem cells in the SVZ.  
Recently, CHD7 was shown to be expressed in the adult SVZ and in the 
subgranular zone (SGZ) of the dentate gyrus in the hippocampus (Feng et al. 
2013).  Additionally, OB and hippocampal neurogenesis was impaired in adult 
Tlx-CreERT2 Chd7 conditional knockout mice (Feng et al. 2013).  These findings 
demonstrate that CHD7 activity is required for ongoing neurogenesis in the 
mature SVZ; however, it is not known whether similar defects are present earlier 
in development or with heterozygous Chd7 deletion.  To investigate these 
questions, I generated conditional Chd7-deficient adult and neonatal mice and 
monitored changes in SVZ proliferation, self-renewal and neuronal differentiation.  
I also examined potential links between CHD7 and RA signaling by modulating 
RA levels in neurosphere assays and during inner ear development.  My findings 
demonstrate that proper Chd7 dosage is required for optimal function of SVZ 
neural stem cells during development and throughout adulthood, while 
modulation of retinoic acid signaling can attenuate inner ear and neural stem cell 
defects that arise from Chd7-deficiency.   
 
Materials and Methods 
Mouse strains, breeding and genotyping.   
Chd7Gt/+ and Chd7flox/flox mice were maintained as previously described 
(Hurd et al. 2007; Hurd et al. 2010).  Ubc-CreERT2, Nestin-Cre and Nestin-
CreERT2  mice were maintained on a C57BL/6 background and mated with 
Chd7flox/flox mice to generate Cre;Chd7flox/+ mice.  Cre;Chd7flox/+ mice were 
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crossed to Chd7flox/flox to produce control (Chd7flox/+ and Chd7flox/flox), Chd7 
conditional heterozygous (Cre;Chd7flox/+), and conditional knockout 
(Cre;Chd7flox/flox) mice. Genomic DNA was isolated from tail and brain tissue and 
PCR genotyped as previously described (Hurd et al. 2010).  All procedures were 
approved by The University of Michigan University Committee on the Use and 
Care of Animals (UCUCA).  
 
Tamoxifen administration.  
Tamoxifen (Sigma-Aldritch, St. Louis, MO) was dissolved in sterile corn oil 
at a concentration of 10 mg/ml.  For adult studies, Tamoxifen (0.2 mg/gbw) was 
administered by intraperitoneal injection to 5 week-old littermate mice once daily 
for five days. Mice were allowed to recover for 14 days, then euthanized and 
processed for further analysis.  For perinatal studies, a single dose of Tamoxifen 
(0.2 mg/gbw) was administered by intraperitoneal injection to pregnant females 
at embryonic day 15.5.   
 
Histology and embedding.   
P1 mice were decapitated, skin was dissected away and heads were 
placed in 4% paraformaldehyde for 4 hrs, then cryoprotected in 30% sucrose, 
embedded in OCT (Tissue Tek, Torrance, CA), frozen and sectioned at 14 µm.  
Adult 7 week-old mice underwent terminal cardiac perfusion with 4% 
paraformaldehyde, then heads were removed, post-fixed with 4% 
paraformaldehyde, cryoprotected in 30% sucrose and embedded in OCT (Tissue 
Tek), then frozen and sectioned at 14 µm.  For histological analyses, sections 
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were stained with hematoxylin and eosin (Sigma) and imaged with bright field 
microscopy on a Leica upright DMRB microscope (Leica Camera AG, Solms, 
Germany) and processed in Photoshop CS5.1 (Adobe, San Jose, CA). 
 
Immunofluorescence.   
Cryosections from 7 week-old and P1 mice (n = 3 per genotype) were 
processed for immunofluorescence with antibodies against CHD7 (1:7500; Cell 
Signaling Technology, Beverly, MA), Ki67 (1:200; Vector Laboratories, 
Burlingame, CA), tyrosine hydroxylase (1:150; Pel-Freeze, Rogers, AR), cleaved 
caspase 3 (1:800, Cell Signaling Technology), calbindin (1:5000; Sigma), GFAP 
(1:500; Sigma), O4 (1:800; Developmental Studies Hybridoma Bank, University 
of Iowa, Iowa City, IA), Tuj1 (1:400; Covance, Princeton, NJ), DCX (1:4000; a gift 
from Jack M. Parent) and SOX2 (1:250; EMD Millipore). All secondary antibodies 
were used at 1:200 with Alexa Fluor 488, Alexa Fluor 555 or biotinylated 
secondary antibodies (Vector Laboratories) conjugated with streptavidin-
Horseradish Peroxidase and Alexa Fluor 488 Tyramide Signal Amplification or 
Alexa Fluor 555 Tyramide Signal Amplification (Life Technologies, Carlsbad, 
CA).  Nuclear staining was performed with 4',6-diamidino-2-phenylindole (DAPI, 
1:100; Life Technologies).  Images were produced by single channel 
fluorescence microscopy on a Leica upright DMRB microscope and processed in 





Olfactory bulb interneuron quantification.   
7 week-old Chd7+/+ and Chd7Gt/+ littermate mice (n = 3 per genotype) were 
processed for immunofluorescence with antibodies against tyrosine hydroxylase, 
calretinin, and calbindin.  Images were captured by single channel fluorescence 
microscopy on a Leica upright DMRB microscope and processed in Adobe 
Photoshop CS5.1.  For quantification of OB interneurons, 25 images using the 
10X objective lens were taken of nine olfactory bulb sections per genotype and 
analyzed using the cell counter function of Image J (National Institutes of Health, 
Bethesda, MD) by sampling ten squares (40 µm x 40 µm) in the granule cell and 
glomerular cell layers.   
 
Fluorescence intensity measurements.   
Tamoxifen-treated 7 week-old mice (n = 3 per genotype) were processed 
for immunofluorescence with antibodies against GFAP and DCX.  Images were 
captured at the same exposure for each antibody by single channel fluorescence 
microscopy on a Leica upright DMRB microscope.  Fluorescence intensity was 
measured on 25-45 images using the 20X objective lens from nine OB, RMS and 
SVZ sections per genotype, then processed in ImageJ by using the freehand 
selection and measurement tool.  Experimental fluorescence intensities and were 






SVZ proliferation and apoptosis studies.   
7 week-old and P1 mice (n = 3 per genotype) were processed for 
immunofluorescence with antibody against Ki67 and cleaved caspase 3.  Nuclei 
were stained with DAPI.  Images were captured by single channel fluorescence 
microscopy on a Leica upright DMRB microscope and processed in Adobe 
Photoshop CS5.1.  For quantification of Ki67+ cells, 36 images using the 20X 
objective lens were taken of nine SVZ sections per genotype and the number of 
Ki67+ cells and total number of cells present in the SVZ was counted using the 
cell counter function of Image J.  For quantification of cleaved caspase 3+ cells, 
27 SVZ sections per genotype were scored for the total number of cleaved 
caspase 3+ cells per section. 
 
Cortex and corpus callosum measurements. 
 7 week-old control, Nestin Cond Het, and Nestin Cond KO mice (n = 3 per 
genotype) were perfusion fixed and brains were sectioned and processed for 
hematoxylin and eosin staining as above.  Cortical thickness measurements 
were made on 27 SVZ sections per genotype by drawing a line perpendicular to, 
and extending from, the lateral ventricle to the outer edge of the cortex.  For 
corpus callosum thickness, measurements were made on 27 SVZ sections per 
genotype by drawing a line at the midline transversely through the corpus 
callosum.  Both measurements were performed using the Leica Applications 





Neurosphere cultures.  
7 week-old adult and P1 mice (n = 3 per genotype) were euthanized, 
whole brain was dissected and coronal sections were cut between the pre-optic 
area and caudal OB.  The lateral wall of the lateral ventricle was microdissected, 
dissociated in trypsin/EDTA (Life Technologies) and DNase1, filtered through a 
0.45 µm mesh (BD Biosciences, East Rutherford, NJ) and counted on a 
hemacytometer.  For primary neurosphere formation assays, 1000 cells were 
plated on ultra-low binding 6 well plates (Corning, Corning, NY) under self-
renewal conditions (media with EGF and FGF), incubated at 37°C with 6.5% CO2 
for 8 days then measured and imaged using an Olympus IX81 motorized inverted 
microscope (Olympus, Tokyo, Japan).  For primary neurosphere differentiation, 
single neurospheres were plated under adherent conditions with FGF and 
without EGF (24 well tissue culture-treated plates (Corning) with poly-D-lysine 
and human fibronectin (Biomedical Technologies, Stoughton, MA)) then 
incubated at 37°C with 6.5% CO2 for 12 days.  Secondary neurospheres were 
generated by dissociating single primary neurospheres and re-plating them under 
self-renewing conditions.  Measurement, counting, imaging and differentiation of 
secondary neurospheres were performed as described for primary neurospheres.  
Neurosphere diameter (n=150 per genotype) was measured using the arbitrary 
line tool in the Olympus cellSens Dimension software package.  Neurosphere 
frequency was determined by counting the total number of neurospheres greater 
than 50 µm in diameter in each well of a 6 well plate and dividing by the total 
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number of cells plated per well.  Statistical significance was determined by 
unpaired Student’s t-test.  
 
Neurosphere differentiation, staining and scoring.   
Primary and secondary neurospheres were differentiated as described 
above then treated with 1:800 anti-O4 antibody for 1 h and fixed with ice cold 
95% ethanol/ 5% glacial acetic acid at -20ºC for 20 min.  Fixed neurospheres 
were blocked for 1 h at room temperature with light rocking with blocking buffer 
(0.05% octylphenoxypolyethoxyethanol (NP-40, Sigma), 2 mg/ml bovine serum 
albumin (Sigma) in phosphate buffered saline).  Alexa Fluor 647 conjugated goat 
anti-mouse IgM (1:500, Life Technologies) diluted in blocking buffer was added 
to each well and incubated at room temperature for 1 h with light rocking.  Each 
well was washed three times with blocking buffer then a cocktail of 1:500 anti-
Tuj1 and 1:200 anti-GFAP primary antibodies was added to each well and 
incubated at room temperature for 1 h with light rocking.  Each well was washed 
three times with blocking buffer then incubated in a cocktail of 1:500 Alexa Fluor 
555 goat anti-mouse IgG2a and 1:500 Alexa Fluor 488 goat anti-mouse IgG1 at 
room temperature for 1 h with light rocking.  Each well was washed three times 
and nuclei were stained with 1:1000 DAPI for 15 min.  Stained colonies were 
imaged with an Olympus IX81 motorized inverted microscope and scored for the 
presence or absence of cell type-specific immunofluorescence (n = 36 
neurospheres per genotype).  Statistical significance was determined by 
unpaired Student’s t-test.  
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Retinoic acid and citral treatment of neurosphere cultures. 
 Neurosphere assays were performed as above on control, Nestin-ERT2 
Cond Het, and Nestin-ERT2 Cond KO P1 mice.  Secondary neurospheres (n = 3 
per genotype) were plated in ultra-low binding 6 well plates in self-renewal 
medium or medium supplemented with 0.1μM retinoic acid (Sigma), 1 μM retinoic 
acid, 1 μM citral (Sigma) or 10 μM citral (n = 18 wells per genotype).  For 
differentiation, untreated secondary neurospheres from each genotype were 
plated in 24 well plates in differentiation medium or medium supplemented with 1 
μM retinoic acid, 1 μM citral, or 10 μM citral (n = 18 neurospheres per condition), 
and scored for differentiation as above. 
 
Embryonic retinoic acid and citral treatment and inner ear paint fills. 
Timed pregnancies were established between Chd7Gt/+ males and females 
with the morning of the plug scored as embryonic day 0.5 (E0.5).  At E7.5, 
pregnant females were treated with either retinoic acid (Sigma; in corn oil at 5 
mg/kg by oral gavage), or citral (Sigma; in corn oil at 3μM/g body weight by 
intraperitoneal injection). At E14.5, Chd7+/+ (n = 12 embryos; 24 ears) and 
Chd7Gt/+ (n = 18 embryos; 36 ears) embryos were dissected and processed for 
inner ear paint filling.  Briefly, embryos were washed in PBS, fixed in Bodian’s 
fixative, cleared in methyl salicylate, heads were bisected and ears were injected 
with a solution with 3% Wite-Out (BIC, Shelton, CT) diluted in methyl salicylate 




Gene expression analysis.   
Subventricular zones from littermate control and Ubc Cond KO P1 mice (n 
= 4 per genotype) were microdissected and RNA was isolated using the 
RNAqueous-Micro RNA Isolation Kit (Ambion, Austin, TX, USA).  cDNA was 
generated using the Superscript First-Strand cDNA Synthesis system with 
random hexamers (Life Technologies).  Relative gene expression levels were 
assayed using TaqMan Gene Expression Master Mix and TaqMan probes 
(Applied Biosystems, Foster City, CA, USA) for Gapdh, Ccnd1, Ccnd2, Cdk4, 
Cdkn1a, Cdkn1b, Rarb, Rxrg, Neurod1, and Sox2 or SYBR Green Master Mix 
(Applied Biosystems) for 45S pre-rRNA (Zentner et al. 2010).  Each sample was 
run in triplicate using an Applied Biosystems StepOne-Plus Real-Time qPCR 
System.  The gene expression level of Gapdh was used as an internal positive 
control.  The difference in threshold cycle (CT) between the assayed gene and 
Gapdh for any given sample was defined as the change in threshold cycle (ΔCT).  
The difference in ΔCT between two samples was defined as ΔΔCT which 
represents a relative difference in expression of the assayed gene.  The fold 
change of the assayed gene relative to Gapdh was defined as 2-ΔΔCT.  Unpaired 
Student’s t-test was performed on Gapdh normalized ΔCT values for each sample 
to determine statistical significance.   
 
P19 neurosphere cultures. 
P19 embryonal carcinoma cells were passaged in MEMα (Life 
Technologies) + 10% FBS (Life Technologies) + 1X penicillin/streptomycin (Life 
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Technologies) and gently treated with 0.25% trypsin. Cells were plated on 0.7% 
agarose in bacterial culture plates in MEMα + 7.5% calf serum + 2.5% FBS + 1 
μM retinoic acid + 1X penicillin/streptomycin. Neurospheres were confirmed to 
form two days after plating by bright field microscopy and medium was changed 
two and four days after initial plating.  Six days after plating, neurospheres were 
collected by gentle centrifugation then fixed for 20 min with formaldehyde and 
processed for chromatin immunoprecipitation.   
 
Chromatin immunoprecipitation and quantitative real-time PCR. 
Chromatin immunoprecipitation with anti-CHD7 antibody (Cell Signaling) 
and normal rabbit IgG (EMD Millipore) was performed using the EZ ChIP 
Chromatin Immunoprecipitation Kit (EMD Millipore) following the manufacturer’s 
instructions on crosslinked P19 neurospheres.  Conserved and non-conserved 
regions within 10 kb of the transcription start site for each of Rarb, Rxrg, and 
Neurod1 were identified using the 60 vertebrate PhastCons track in the UCSC 
Genome Browser (build GRCm38/mm10) (Siepel et al. 2005).  A conserved 
region was defined by a series of adjacent LOD score hits conserved in ≥ 80% of 
the vertebrates.  Primers were designed against nine conserved regions and one 
non-conserved region for each gene and assayed for a single melting point by 
quantitative real-time PCR (qRT-PCR) melt curve analysis using SYBR-Green 
reagents (Applied Biosystems).  Primer pairs which demonstrated non-specific 
amplification were removed prior to further analysis.  Nine replicates of qRT-PCR 
were performed on the input, IgG, and anti-CHD7 samples for each primer pair.  
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Percent input was calculated for both the IgG and anti-Chd7 samples across 
each primer pair. 
 
Results 
Chd7-deficient mice display neuronal defects in the adult olfactory bulb 
and rostral migratory stream. 
I sought to determine the cell type specificity of Chd7 in the mature mouse 
OB and to clarify whether Chd7 is required for proper formation and maintenance 
of OB interneurons.  In the adult OB, CHD7 co-localized with markers of 
immature (Doublecortin, DCX) and mature interneurons (Calbindin, CALB, 
Calretinin, CALR and Tyrosine Hydroxylase, TH) (Fig. 2.1) consistent with 
recently published observations (Feng et al. 2013).   In the OB glomerular layer 
of Chd7Gt/+ mice, there were 35% fewer CALB+ cells, 48% fewer TH+ cells, and 
no change in the number of CALR+ cells compared to wild type (Fig. 2.2C-E, F-
H, I-K).  In the OB granule cell layer of Chd7Gt/+ mice, there were 15% fewer 
CALR+ cells compared to wild type (Fig. 2.2F-H). My data are consistent with a 
recent report showing reduced numbers of olfactory interneurons in adult Tlx-
CreERT2 Chd7 conditional knockout mice (Feng et al. 2013), and suggest that 
haploinsufficiency of Chd7 also disrupts mature OB interneurons. 
There are no reported cases of humans with homozygous CHD7 
mutations, and mice with complete loss of Chd7 die by embryonic day 11 (E11), 
presumably from cardiovascular defects (Bosman et al. 2005; Hurd et al. 2007).  
To study the postnatal effects of complete Chd7 deficiency, I used Chd7flox/flox 
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and Ubc-CreERT2 mice which ubiquitously express a Tamoxifen-inducible Cre 
(Ruzankina et al. 2007).  Five week-old control (Chd7flox/+ or Chd7flox/flox), Ubc 
conditional heterozygous (Ubc-CreERT2; Chd7flox/+, Ubc Cond Het), and Ubc 
conditional knockout (Ubc-CreERT2; Chd7flox/flox, Ubc Cond KO) mice were 
treated with Tamoxifen by daily intraperitoneal injection for five days, then 
allowed to recover for 14 days (Fig. 2.3A).  Immunofluorescence and 
fluorescence intensity (FI) quantification on coronal cryosections of the OB from 
control, Ubc Cond Het, and Ubc Cond KO adult mice was performed to 
characterize DCX+ migrating neurons and Glial Fibrillary Acidic Protein+ (GFAP) 
glia in the RMS and OB.  In the RMS, there was a reduction in DCX-FI and a 
corresponding increase in GFAP-FI in Ubc Cond Het and Ubc Cond KO mice 
compared to controls (Fig. 2.3C-E, I, J).  Interestingly, GFAP-FI was also 
increased in the glomerular layer (GL) of the OB in Ubc Cond KO mice compared 
to controls (Fig. 2.3F,H,K), while Ubc Cond Het mice were unaffected (Fig. 
2.3F,G,K).  Thus, adult-onset reduction of Chd7 dosage leads to fewer immature 
and mature OB neurons and a visible expansion of glia, consistent with ongoing 
postnatal requirements for Chd7. 
 
Reduced Chd7 dosage leads to neurogenic and proliferative defects in the 
adult mouse SVZ. 
 Reduction of neurons in the olfactory bulb could be due to abnormalities in 
SVZ-derived neuronal production, migration, differentiation or survival.  In the 
SVZ, CHD7 was present in a subset of neural stem and progenitor cells marked 
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by GFAP and SOX2 (Fig. 2.4C,D).  In the RMS, CHD7 co-localized with DCX+ 
neuroblasts (progeny of SOX2+ SVZ cells), and was absent in GFAP+ glia (Fig. 
2.4E,F).  Therefore, Chd7 is expressed in SVZ neural stem and progenitor cells 
and continues to be expressed in DCX+ neuroblasts as they migrate through the 
RMS into the olfactory bulb where they differentiate into mature interneurons.  
These data are in agreement with co-localization studies by Feng et al., which 
showed CHD7 present in a subset of GFAP+ neural stem cells as well as the 
majority of Mash1+ neural progenitors and DCX+ neuroblasts (Feng et al. 2013).  
Next, I examined whether loss of Chd7 leads to abnormalities in SVZ and 
RMS of adult mice.  Hematoxylin and eosin (H&E) staining of SVZ tissue from 
Ubc Cond KO adult mice revealed ventriculomegaly, consistent with 
hydrocephalus (Fig. 2.5A,C), while Ubc Cond Het mice were unaffected (Fig. 
2.5B).  Immunofluorescence with anti-CHD7 confirmed deletion of CHD7+ cells in 
the SVZ of Ubc Cond Het and Ubc Cond KO mice compared to controls (Fig. 
2.5D-F).  As observed in the OB (Fig. 2.3J), there was decreased DCX-FI, 
disorganization of the RMS, and increased GFAP-FI in the RMS of adult Ubc 
Cond Het and Ubc Cond KO adult mice as compared to controls (Fig. 2.5G-I).  
The trend of decreased DCX-FI and increased GFAP-FI was also observed in 
adult Ubc Cond KO SVZ as compared to controls (Fig. 2.6).  These observations 
suggest that Chd7 is required for proper maintenance of the SVZ stem cell niche 
and the rostral migratory stream.  The number of proliferating Ki67+ cells was 
reduced by 11% in the SVZ of Ubc Cond KO compared to controls and was 
unchanged in Ubc Cond Het mice (Fig. 2.5J-M), consistent with a minor role for 
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Chd7 in positive regulation of mature SVZ neural stem and progenitor cell 
proliferation.  My results differ slightly from Feng et al., who showed no 
abnormalities in proliferating cells in the SVZ of adult Tlx-CreERT2 Chd7 
conditional knockout mice (Feng et al. 2013).  This difference may reflect the 
timing of tamoxifen-induced deletion, assay sensitivity, or the specificity/efficiency 
of the Cre line.   
Considering that Ubc-CreERT2 deletes Chd7 in all cells, ventriculomegaly 
and SVZ deficits may be influenced by secondary, non-cell autonomous deletion 
of Chd7 in tissues or cells that interact with the SVZ.  To test this, I used Nestin-
Cre mice which express a neural stem cell-specific Cre that is active by 
embryonic day 11 (E11) in the central nervous system (Tronche et al. 1999; 
Sclafani et al. 2006).  Ki67+ cells in the SVZ of adult Nestin Cond KO were 
reduced by 15% compared to controls and were unchanged in Nestin Cond Het 
(Fig. 2.5N-Q), consistent with mild lineage specific proliferative defects. 
Since E11-E15 is a period of active cortical neurogenesis (Marin et al. 
2001), Nestin Cond KO mice were tested for defects in forebrain structures 
including the cortex, corpus callosum, and lateral ventricles.  H&E staining of 
forebrains revealed no differences in thickness of the cortex or corpus callosum 
between adult control and Nestin Cond KO mice (Fig. 2.7).  Similar to adult Ubc 
Cond KO mice, Nestin Cond KO also displayed ventriculomegaly.  Thus, Nestin-
Cre mediated loss of Chd7 in the brain results in ventriculomegaly without major 




SVZ neural stem and progenitor cells exhibit impaired proliferation, self-
renewal and neurogenesis in Chd7-deficient adult mice. 
To test whether Chd7 is necessary for maintenance of proliferation, self-
renewal, and multipotency of SVZ neural stem and progenitor cells, I generated 
and analyzed neurospheres from the SVZ of adult mice (Reynolds et al. 1992; 
Pastrana et al. 2011).  The neurosphere assay can be used to determine the in 
vitro potential of a stem cell population, and to explore the regulatory 
mechanisms underlying self-renewal and differentiation (Fig. 2.8A-C).  Ubc Cond 
Het and Ubc Cond KO primary neurospheres were smaller than controls, but 
there were no differences in primary neurosphere frequency (Fig. 2.8D,E).  To 
test the self-renewal potential of neural stem and progenitor cells over time, I 
generated secondary neurospheres by dissociating and re-plating primary 
neurospheres under non-adherent conditions (Fig. 2.9).  Ubc Cond KO 
secondary neurospheres were smaller than controls, while Ubc Cond Het 
secondary neurosphere size was unchanged (Fig. 2.8G).  There were fewer Ubc 
Cond Het and Ubc Cond KO secondary neurospheres compared to controls (Fig. 
2.8H).  Both primary and secondary neurospheres from Nestin Cond Het and 
Nestin Cond KO mice were reduced in size and frequency in a Chd7 dosage-
dependent and cell-autonomous manner (Fig. 2.8J-K, M-N).  
A hallmark of stem cells derived from neural tissue is their ability to 
differentiate in vitro into the three major cell types present in the central nervous 
system: glia (GFAP+), oligodendrocytes (O4+), and neurons (TUJ1+) (Alvarez-
Buylla et al. 2001).  TUJ1+ colonies derived from Ubc Cond Het, Ubc Cond KO, 
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and Nestin Cond KO adult secondary neurospheres, and Nestin Cond KO 
primary neurospheres, were significantly reduced compared to controls (Fig. 
2.8I,L,O).  Alternatively, neuronal potentials of Ubc Cond Het, Ubc Cond KO, and 
Nestin Cond Het primary neurospheres were unaffected compared to controls 
(Fig. 2.8F,L).  Oligodendrocyte and glial potentials were normal for all Ubc and 
Nestin Cond Het and Cond KO neurospheres (data not shown).  Due to the 
plating of whole, undissociated neurospheres for differentiation, I was unable to 
quantify specific lineages beyond presence or absence in the culture dish; thus, 
experimentally induced increases in glial cells would not be detected in this 
assay.  I conclude that Chd7-deficient neurospheres exhibit cell-autonomous 
reductions in neuronal potential, with preserved or potentially enhanced 
differentiation into both oligodendrocytes and astrocytes. 
 
Perinatal mice with reduced Chd7 dosage have impaired proliferation, self-
renewal and neurogenesis of SVZ neural stem and progenitor cells.  
In the rodent SVZ, OB neurogenesis is a lifelong process that begins 
during late embryogenesis and continually populates the olfactory bulb with new 
interneurons (Luskin 1993; Wichterle et al. 2001).  Considering that Nestin-Cre is 
active in utero before E11, defects in SVZ neural stem cell proliferation in Nestin-
Cre Chd7 CKO mice could be secondary to early Chd7 deletion.  In order to 
determine whether late embryonic Chd7 deletion impacts perinatal SVZ function, 
I induced deletion of Chd7 with Ubc-CreERT2 and Nestin-CreERT2 (Ables et al. 
2010) at E15.5 (Fig. 2.10A), when mouse SVZ neural stem cells begin to 
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transition from cortical neurogenesis to olfactory bulb neurogenesis (Anderson et 
al. 1997).  In the SVZ of postnatal day 1 (P1) Ubc Cond KO and NestinERT2 
Cond KO mice, there were 38% and 37% fewer Ki67+ cells than controls, 
whereas Ki67+ cells in Ubc Cond Het and NestinERT2 Cond Het mice were 
unchanged (Fig. 2.10B-I), consistent with impaired proliferation.  Additionally, 
there was no change in apoptosis frequency in the SVZ of NestinERT2 Cond Het 
and NestinERT2 Cond KO perinatal mice compared to controls (Fig. 2.10K-N). 
To explore potential mechanisms for the moderate decrease in SVZ 
proliferation with loss of Chd7, I performed quantitative RT-PCR for genes 
involved in proliferation and cell cycle regulation on RNA derived from SVZ of 
control and Ubc Cond KO perinatal mice (Fig. 2.11).  There were no significant 
changes in expression of the positive cell cycle regulators Ccnd1 (cyclinD1), 
Ccnd2 (cyclinD2), and Cdk4, or the negative regulators Cdkn1a (p21Cip1) and 
Cdkn1b (p27Kip1) (Beukelaers et al. 2012).  Previous studies in mouse embryonic 
stem cells have demonstrated that CHD7 directly binds to precursor ribosomal 
RNA genes (rRNA) and regulates their transcription, resulting in global 
reductions in cell proliferation and protein levels upon loss of Chd7 (Zentner et al. 
2010).  I observed a 26% reduction in 45S pre-rRNA transcripts in RNA isolated 
from Ubc Cond KO SVZ compared to controls (Fig. 2.10J).  This is consistent 
with the 20-40% decrease in rRNA in Chd7-deficient mouse embryonic stem 
cells, inner ears, and eyes reported by Zentner et al. (Zentner et al. 2010). These 
data suggest that CHD7 effects on SVZ cell proliferation may be caused by 
global reductions in protein translation and ribosomal RNA.   Importantly, my 
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studies do not rule out the possibility of smaller effects of CHD7 on other 
downstream genes that, in combination, may exert robust effects on the cell 
cycle.   
I then tested the in vitro proliferation, self-renewal, and differentiation 
capacity of neonatal Chd7-deficient SVZ neural stem and progenitor cells by 
generating primary neurospheres from control, Ubc Cond Het, Ubc Cond KO, 
Nestin-ERT2 Cond Het, and Nestin-ERT2 Cond KO P1 mice (Figs. 2.12 and 
2.13).  As in adult mice, primary and secondary neurospheres from Ubc Cond 
KO and Nestin-ERT2 Cond KO mice were reduced in size, frequency, self-
renewal, and neuronal potential compared to controls.  Neurospheres from Ubc 
Cond Het and Nestin-ERT2 Cond Het mice exhibited intermediate phenotypes, 
with milder reductions compared to Cond KO mice.  Together, the in vivo 
proliferation and in vitro neurosphere data from neonatal mice indicate that Chd7 
deficiency contributes to altered SVZ neural stem and progenitor cell function as 
early as P1. 
 
Modulation of retinoic acid signaling attenuates defects in Chd7-deficient 
neurospheres and semicircular canals. 
Retinoic acid (RA) signaling is necessary for proper development and 
maintenance of the forebrain and olfactory bulbs (LaMantia et al. 1993).  RA 
treatment of neurospheres promotes self-renewal and neuronal differentiation 
(Wang et al. 2005), while inhibition of retinoic acid signaling leads to fewer, but 
larger neurospheres (Haskell et al. 2005).  I hypothesized that alteration of RA 
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signaling by addition of RA or citral (inhibitor of RA synthesis) (Kikonyogo et al. 
1999) in SVZ neurosphere cultures may influence the size, self-renewal and/or 
neuronal differentiation of Chd7-deficient neurospheres.  Treatment of secondary 
neurospheres with RA produced smaller and more abundant neurospheres from 
control, Nestin-ERT2 Cond Het, and Nestin-ERT2 Cond KO mice (Fig. 2.14A,B).  
Interestingly, RA increased neuronal potential by 46% in Nestin-ERT2 Cond KO 
secondary neurospheres, suggesting partial rescue of the observed neuronal 
differentiation defect (Fig. 2.14E).   
Nestin-ERT2 Cond Het and Nestin-ERT2 Cond KO secondary 
neurospheres increased in size by 19% and 39%, respectively, with 10 µM citral 
treatment, whereas the control was unchanged (Fig. 2.14C).  Self-renewal of 
Nestin-ERT2 Cond Het and Nestin-ERT2 Cond KO secondary neurospheres was 
reduced by 15% and 27%, respectively, with 10 µM citral exposure, while self-
renewal of control neurospheres was decreased by 58% (Fig. 2.14D).  These 
data indicate that reduced Chd7 dosage may confer protection against the 
reduction in self-renewal that occurs with citral treatment.   Citral treatment did 
not alter the neuronal potential of control, Nestin-ERT2 Cond Het, and Nestin-
ERT2 Cond KO secondary neurospheres (Fig. 2.14F).  I conclude that decreased 
RA signaling does not further inhibit neuronal differentiation in Chd7-deficient 
neurospheres.  Interestingly, glial and oligodendrocyte potential was unaffected 
for all genotypes regardless of RA or citral exposure (data not shown).  My 
results provide evidence that increased RA signaling partially attenuates 
neuronal differentiation defects in Chd7-deficient neurospheres, without affecting 
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size or self-renewal.  Conversely, inhibition of RA signaling with citral (1) 
moderately corrects size deficits in Chd7 Cond Het and Cond KO neurospheres, 
(2) partially protects against further reduction of self-renewal capacity, and (3) 
has no effect on neuronal differentiation.   
To test the in vivo effects of RA modulation in Chd7-deficient mice, I chose 
to investigate the inner ear, a tissue that displays highly penetrant defects and is 
easily accessible to pharmacological manipulation (Hurd et al. 2010; Hurd et al. 
2011).  Inner ears from Chd7Gt/+ mice displayed truncation or agenesis of the 
E14.5 lateral semicircular canal (LC) (Fig. 2.14G,J) that was more severe after in 
utero exposure to RA (Fig. 2.14H,K).  Interestingly, intrauterine citral treatment 
had no effect on wild-type ears (18/18) and on most Chd7Gt/+ inner ears (20/28), 
whereas in roughly one-third of Chd7Gt/+ inner ears (8/28), citral fully prevented 
the semicircular canal defects (Fig. 2.14L, Fig. 2.15).  This rescue or prevention 
of inner ear defects in Chd7-deficient ears with modulation of RA levels suggests 
a mechanistic interaction between CHD7 function and RA signaling. 
 
Chd7 directly regulates RA receptor and neuronal differentiation genes in 
neural stem and progenitor cells. 
 Given that CHD7 regulates transcription through chromatin remodeling 
(Hurd et al. 2010; Layman et al. 2011; Bouazoune et al. 2012), I predicted that 
loss of Chd7 may disrupt expression of genes coding for transcription factors and 
retinoic acid signaling mediators involved in neuronal differentiation.  To test this, 
I selected three genes (Rarb, Rxrg, and Neurod1) known to be involved in either 
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SVZ neurogenesis or neuronal differentiation by qRT-PCR.  Rarb and Rxrg 
encode receptors that facilitate RA signaling (Rochette-Egly et al. 2009) and 
Neurod1 encodes a basic helix-loop-helix transcription factor that promotes 
neuronal differentiation (Roybon et al. 2009).  In Ubc Cond KO P1 SVZ, 
expression of Rarb, Rxrg, and Neurod1 was reduced by 58%, 57%, and 55%, 
respectively, relative to controls (Fig. 2.16A).  Consistent with prior studies 
showing that CHD7 and SOX2 interact in neural stem cells (Engelen et al. 2011), 
Sox2 expression was unchanged in the SVZ of P1 Ubc Cond KO mice relative to 
control.  Therefore, loss of Chd7 results in down-regulation of key retinoic acid 
and neuronal differentiation genes but does not affect global expression of neural 
stem cell specific genes. 
To determine whether CHD7 participates in a complex that binds directly 
to Rarb, Rxrg, and Neurod1 promoter regions, I performed chromatin 
immunoprecipitation (ChIP) on chromatin isolated from P19 mouse embryonal 
carcinoma cells followed by qRT-PCR at evolutionarily conserved promoter 
regions.  P19 cells are known to form neural stem cell-like neurospheres and 
differentiate in response to RA (McBurney et al. 1988; MacPherson et al. 1997).  
I observed enrichment for CHD7 at a subset of conserved promoter regions for 
Rarb, Rxrg, and Neurod1 (Fig. 2.16B-D).  Additionally, CHD7 was not bound to 
non-conserved regions in these genes.  Together, my findings data provide new 
insights into interactions between RA signaling pathways and CHD7 in neural 





Here I show that Chd7 is expressed throughout the SVZ, RMS, and OB in 
adult mice.  In both the adult and neonatal mouse, conditional loss of Chd7 leads 
to proliferative, self-renewal, and neurogenic deficits both in vivo and in vitro with 
preserved or enhanced glial potential.  Modulation of retinoic acid signaling by 
treatment with retinoic acid increases neuronal potential of Chd7-deficient 
neurospheres, while inhibition of retinoic acid signaling attenuates size and self-
renewal deficits.  Additionally, inhibition of retinoic acid signaling in vivo leads to 
correction of semicircular canal defects in the inner ears of Chd7-deficient mouse 
embryos.  Expression of key retinoic acid receptor genes (Rarb, Rxrg) and at 
least one neurogenic transcription factor gene (Neurod1) is significantly reduced 
in the Chd7 knockout SVZ; moreover, these genes are directly bound by CHD7-
containing complexes in P19 neurospheres.  Together, these findings indicate 
that Chd7 and RA signaling promote proliferation, self-renewal, and 
neurogenesis during late embryogenesis and into adulthood, thereby suggesting 
a therapeutic avenue for intervention during pregnancy.  
I propose a model whereby CHD7 regulates retinoic acid signaling and 
pro-neuronal genes to facilitate the transition from neural progenitor cell to 
neuroblast (Fig. 2.16E).  Chd7-deficiency also leads to decreased progenitor cell 
differentiation into neuroblasts and a shift in cell fate towards the glial lineage.  
Interestingly, in vitro modification of retinoic acid signaling partially compensates 
for loss of Chd7, but does not fully correct the observed deficits in size, self-
renewal, and neuronal differentiation. Like retinoic acid, CHD7 has been shown 
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to participate in several signaling pathways including Wnt (Takada et al. 2007), 
BMP (Hurd et al. 2012), FGF (Hurd et al. 2010; Layman et al. 2011; Hurd et al. 
2012), and Notch (Hurd et al. 2012).  Loss of Chd7 in the SVZ and inner ear may 
cause deficits in these pathways, potentially explaining the partial rescue of 
neurosphere and inner ear defects by RA modulators. 
Disrupted retinoic acid signaling leads to a variety of organ defects, many 
of which occur with Chd7-deficiency including abnormalities of the eye, heart, 
urogenital system, brain, and skeleton (Mark et al. 2009; Janssen et al. 2012).  
Treatment of Nestin-lineage Chd7-deficient neurospheres with retinoic acid 
increased neuronal potential, whereas citral treatment restored neurosphere size 
to control levels. Two retinoic acid receptor genes, Rarb and Rxrg, were also 
down-regulated in Ubc Cond KO SVZ.  Interestingly, CHD7 was present in a 
complex that was directly bound to the highly conserved promoter regions of 
Rarb and Rxrg in P19 neurospheres.  In the SVZ, reduced or absent retinoic acid 
signaling results in proliferative and neurogenic defects both in vivo and in vitro 
during development and in the adult, while increased retinoic acid leads to 
increased neurogenesis (Haskell et al. 2005; Wang et al. 2005).  Consistent with 
these studies, my data imply a direct relationship between CHD7 and retinoic 
acid signaling that may contribute to the defects associated with CHARGE 
syndrome. 
My findings also imply that decreased numbers of OB interneurons 
derived from the SVZ may contribute to OB hypoplasia in Chd7-deficient mice, in 
addition to the influence of reduced olfactory sensory neurons, as previously 
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reported (Layman et al. 2009).  This result is in agreement with recently 
published data showing reduced olfactory bulb interneurons in adult mice with 
Tlx-CreERT2 mediated conditional deletion of Chd7 (Feng et al. 2013).  
Interestingly, the magnitude of olfactory bulb interneuron reductions was similar 
(40-60%) in my study and that of Feng et al., suggesting that reduction of Chd7 
gene function below 50% may not lead to further impairments in olfactory bulb 
development.  Additionally, I observed ventriculomegaly in Chd7-deficient adult 
mice, consistent with a recent study of 40 CHD7 mutation positive human fetuses 
which demonstrated a variety of brain malformations including arrhinencephaly 
and ventriculomegaly (Legendre et al. 2012).  Similar to my data, disruption of 
SVZ neural stem cell function results in ventriculomegaly in mouse models of 
Bardet-Biedl syndrome and Sox2-deficiency (Ferri et al. 2004; Carter et al. 2012).  
CHD7 has been shown to regulate neurogenesis in the adult dentate gyrus of the 
hippocampus (Feng et al. 2013) and is also implicated in autism spectrum 
disorder (O'Roak et al. 2012).  My findings therefore add to a growing body of 
work supporting a specific role for CHD7 function in SVZ, SGZ and olfactory 
neural stem cells, and perhaps in other regions of the nervous system that are 
affected in CHARGE.  Notably, CHARGE individuals can also present with 
hindbrain and cerebellar abnormalities (Jongmans et al. 2006; Sanlaville et al. 
2006; Sanlaville et al. 2007; Legendre et al. 2012), and future studies should help 
clarify whether CHD7 also regulates neural stem and progenitor cells in these 
regions.  My work opens new avenues for investigation of CHD7 activity in stem 
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cell populations affected by CHARGE syndrome, and should help guide future 
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Figure 2.1: CHD7 co-localizes with immature and mature olfactory bulb neurons. 
(A) Schematic sagittal view of an adult mouse brain showing location of coronal sections through 
the olfactory bulb (OB) in (C-F) (dotted line, OB).  (B) Schematic of a DAPI-stained coronal 
section through the olfactory bulb denoting location of panel C in the rostral migratory stream 
(RMS, yellow box) and panels (D-F) in the glomerular layer (GL, orange box). (C-F) 
Immunofluorescence on adult tissues shows CHD7 co-localization (denoted with white 
arrowheads) with Doublecortin (DCX) in immature neurons in the RMS (C), with Tyrosine 
hydroxylase (TH) in dopaminergic interneurons (D) and with Calbindin (CALB) and Calretinin 




Figure 2.2: Adult heterozygous Chd7 mice have fewer mature olfactory bulb interneurons. 
(A) Schematic sagittal view of an adult mouse brain showing location of coronal sections through 
the olfactory bulb (OB) in (C,D,F,G,I,J) (dotted line, OB).  (B) Schematic of a DAPI-stained 
coronal section through the olfactory bulb denoting location of panels (C,D,F,G,I,J) in the 
glomerular and granule cell layers (GL, GCL, orange box).  Immunolabeling with anti-Calbindin 
(CALB, C,D), anti-Calretinin (CALR, F,G) and anti-Tyrosine hydroxylase (TH, I,J) antibodies in 
wild type and Chd7 heterozygous null (Chd7Gt/+) mice shows 35% and 48% reductions in the 
number of CALB+ and TH+ interneurons in the GL, respectively, and 15% reduction in the 
number of CALR+ interneurons in the GCL of Chd7Gt/+ mice compared to wild type (E,H,K).  
Scale bars in (C,D), (F,G), (I,J): 75 μm.  Error bars in (E,H,K) indicate standard error of the mean 
(SEM) (n=3 per genotype).  *p<0.05, ***p<0.001 by unpaired Student’s t-test.  Other 





Figure 2.3: Chd7-deficiency results in fewer immature neurons with glial expansion in the adult 
olfactory bulb. 
(A) Schematic showing the Tamoxifen dosing regimen for adult mice. At five weeks of age, mice 
were treated with a single dose of Tamoxifen (0.2 mg/gbw) by daily intraperitoneal injection for 
five days, allowed to recover for 14 days then processed for frozen sectioning.  (B) Schematic of 
a DAPI-stained coronal section through the olfactory bulb denoting location of panels (C-E) in the 
rostral migratory stream (RMS, yellow box) and panels (F-H) in the glomerular layer (GL, orange 
box).   
(C-E) Immunofluorescence on coronal sections through the OB showing reduced DCX+ 
neuroblasts in the RMS of Ubc Cond Het (D) and Ubc Cond KO (E) mice compared to control (C, 
quantified in I).  Immunofluorescence on coronal sections through the OB showing increased glia 
in the RMS (C-E) and GL (F-H) of Ubc Cond Het (D,G) and Ubc Cond KO (E,H) mice compared 
to control (C,F, quantified in J,K).  Scale bars in (C-E), (F-H): 75 μm.  Error bars in (I-K) indicate 






Figure 2.4: Chd7 is expressed in neural stem cells and neuroblasts in the adult mouse SVZ and 
RMS. 
(A) Schematic sagittal view of an adult mouse brain showing location of coronal sections through 
the subventricular zone (SVZ) of the lateral ventricle (LV) in (C,D) (dotted line, LV) and sections 
through the RMS in (E,F) (dotted line, RMS). (B) Diagram of a coronal section through adult 
mouse forebrain showing the area of SVZ (orange box) imaged in (C,D).  Double 
immunofluorescence shows that CHD7 co-localizes with a subset of SOX2+ (white arrows, C) 
and GFAP+ (white arrows, D) neural stem and progenitor cells, but not with corpus callosum 
GFAP+ glial cells (D).  In the RMS, CHD7 co-localizes with DCX in migrating neuroblasts and 
immature neurons (white arrows, E) and CHD7+ cells are surrounded by a sheath of GFAP+ glia 
(F). Scale bars in (C,E,F): 75 μm, (D): 25 μm.  Other abbreviations: Str: striatum, Sep: septum, 





Figure 2.5:  Loss of Chd7 leads to ventriculomegaly and mild proliferative defects in the adult 
mouse SVZ. 
(A-I) Hematoxylin and eosin staining and immunofluorescence analysis of adult SVZ in control, 
Ubc Cond Het and Ubc Cond KO mice. (A-C) Reduced Chd7 dosage results in ventriculomegaly 
in Ubc Cond KO (C) mice compared to control and Ubc Cond Het (A,B).  (D-F) CHD7 
immunofluorescence is decreased in Ubc Cond Het (E) and Ubc Cond KO SVZ (F) compared to 
control (D), confirming gene deletion.  (G-I) DCX-positive neuroblasts are reduced in the RMS in 
Ubc Cond Het (H) and Ubc Cond KO (I) mice compared to control (G).  (J-L) and (N-P) 
Representative coronal sections through the SVZ of adult control (J,N), Ubc Cond Het (K), Ubc 
Cond KO (L), Nestin Cond Het (O) and Nestin Cond KO (P) mice processed for 
immunofluorescence with anti-Ki67 antibody and counterstained with DAPI.(M,Q) Quantification 
showing the percentage of Ki67+ cells relative to the total number of DAPI-stained cells in control, 
Ubc Cond Het and Ubc Cond KO and control, Nestin Cond Het and Nestin Cond KO.  The 
percentage of Ki67+ cells in the SVZ of Ubc Cond KO and Nestin Cond KO adult mice is 
decreased by 11% and 15%, respectively, compared to controls. Scale bars in (A-I), (J-L), (N-P): 






Figure 2.6: Chd7-deficient adult SVZ displays loss of neuroblasts and increased glia. 
(A,B) and (D,E) show immunofluorescence of coronal sections from adult control and Ubc Cond 
KO SVZ for neuroblasts (DCX, A,B) and neural stem cells/glia (GFAP, D,E). There is a 76% 
reduction in DCX immunofluorescence and a 61% increase in GFAP immunofluorescence 
between control and Ubc Cond KO brains (quantified in C,F) . Error bars in (C,F) indicate SEM 
(n=3 per genotype).  ***p<0.001 by unpaired Student’s t-test. Other abbreviations: FIU: 





Figure 2.7: Cortex and corpus callosum size are unchanged in adult Nestin-Cre conditional Chd7 
knockout mice. 
(A,B) and (D,E) show hematoxylin and eosin staining of coronal sections from adult control and 
Nestin Cond KO cortex (Ctx) and corpus callosum (CC), respectively. There are no differences in 
thickness of cortex and corpus callosum between control and Nestin Cond KO brains as 
quantified in (C) and (F), but enlarged lateral ventricles are present in Nestin Cond KO brains (E) 





Figure 2.8: Neural stem cells derived from adult Chd7 conditional knockout mice exhibit impaired 
proliferation, self-renewal, and neuronal potential. 
(A-C) Representative images of neurospheres derived from SVZ tissue of adult control (A), Ubc 
Cond Het (B), and Ubc Cond KO (C) mice. (D-F), (G-I), (J-L), and (M-O) show quantification of 
primary and secondary neurosphere size (μm), primary neurosphere frequency, secondary 
neurosphere self-renewal (expressed as the number of secondary neurospheres formed from a 
single primary neurosphere) and percentage of neuronal lineage-positive (TUJ1+) differentiated 
adherent neurospheres from control, Ubc Cond Het, Ubc Cond KO, Nestin Cond Het, and Nestin 
Cond KO adult mice.  Neurospheres derived from Ubc Cond Het and Ubc Cond KO adult mice 
exhibit Chd7 dosage-dependent reductions in primary neurosphere size (D), as well as secondary 
neurosphere size (G) and self-renewal (H) compared to controls.  Neurospheres generated from 
Nestin Cond Het and Nestin Cond KO adult mice show Chd7 dosage-dependent reductions in 
primary neurosphere size (J) and frequency (K), and secondary neurosphere size (M) and self-
renewal (N), compared to controls.  (E) There is no change in Ubc Cond Het or Ubc Cond KO 
primary neurosphere frequency compared to controls.  (I,L,O) Neuronal potential is reduced by 
61% in Ubc Cond KO secondary neurospheres (I), 42% in Nestin Cond KO primary neurospheres 
(L) and 44% in Nestin Cond KO secondary neurospheres (O) compared to controls.  There is no 
change in neuronal potential of Ubc Cond Het or Ubc Cond KO primary neurospheres compared 
to controls (F).  Scale bars in (A-C): 100 μm.  Error bars in (D-O) indicate SEM (n=3 per 
genotype).  *p<0.05, **p<0.01, ***p<0.001 by unpaired Student’s t-test.  Other abbreviations: 




Figure 2.9: Reduction of Chd7 dosage leads to decreased adult SVZ-derived neurosphere size. 
(A-C) Representative images of primary neurospheres derived from SVZ of adult control (A), Ubc 
Cond Het (B) and Ubc Cond KO mice (C).  (D-I) Representative images of primary and 
secondary neurospheres derived from SVZ of adult control (D,G), Nestin Cond Het (E,H) and 





Figure 2.10: Postnatal day 1 Chd7 conditional knockout mice display reduced SVZ proliferation. 
(A) Schematic showing the Tamoxifen dosing regimen where pregnant females received a single 
intraperitoneal injection of Tamoxifen (0.2 mg/gbw) at embryonic day 15.5 (E15.5). (B-D), (F-H), 
and (K-M) Representative coronal sections showing immunofluorescence for the proliferative 
marker Ki67 or apoptosis marker cleaved caspase 3 (Casp3) with DAPI counterstain in the SVZ 
of postnatal day 1 (P1) control (B,F,J), Ubc Cond Het (C), Ubc Cond KO (D), Nestin-ERT2 Cond 
Het (G,K), and Nestin-ERT2 Cond KO (H,L) mice.  (E,I) Quantification showing the percentage of 
Ki67+ cells relative to the total number of DAPI-stained cells in control, Ubc Cond Het, and Ubc 
Cond KO (E), and Nestin-ERT2 Cond Het and Nestin-ERT2 Cond KO (I) P1 SVZ.  The 
percentage of Ki67+ cells are reduced by 37% and 38% in the SVZ of Ubc Cond KO and Nestin-
ERT2 Cond KO P1 mice, respectively, compared to controls.  (J) Quantitative PCR shows that 
45S pre-rRNA is decreased by 26% in Ubc Cond KO SVZ compared to controls.  (K-N) There is 
no change in the number of cleaved caspase 3+ (Casp3) cells per section in Nestin-ERT2 Cond 
Het (L) and Nestin-ERT2 Cond KO (M) P1 SVZ compared to control (K). Scale bars in (B-D), (F-
H): 75 μm, (K-M): 50 μm.  Error bars in (E,I,J,N) indicate SEM (n=3 per genotype).  *p<0.05, 




Figure 2.11: Cell cycle and proliferation markers are unchanged with loss of Chd7 in the perinatal 
SVZ. 
Quantitative RT-PCR on RNA isolated from SVZ of P1 control and Ubc Cond KO mice shows no 
changes in expression of proliferation or cell cycle regulatory genes CyclinD1 (Ccnd1), CyclinD2 
(Ccnd2), Cdk4 (Cdk4), p21Cip1 (Cdkn1a) and p27Kip1 (Cdkn1b) .  Black dashed line indicates 





Figure 2.12: Neurospheres derived from postnatal day 1 Chd7 conditional knockout mice exhibit 
impaired proliferation, self-renewal and neuronal potential. 
(A-L) Quantification of the size (μm) of primary and secondary neurospheres, frequency of 
primary neurospheres, self-renewal and percentage of neuronal lineage-positive (TUJ1+) 
differentiated adherent neurospheres from control, Ubc Cond Het, Ubc Cond KO, Nestin-ERT2 
Cond Het and Nestin-ERT2 Cond KO P1 mice.  There are Chd7 dosage-dependent reductions in 
primary neurosphere size (A) and frequency (B) and secondary neurosphere size (D) and self-
renewal (E) from Ubc Cond Het and Ubc Cond KO P1 mice compared to controls.  Chd7 dosage-
dependent reductions are also present in primary neurosphere frequency (H) and secondary 
neurosphere size (J) and self-renewal (K) in Nestin-ERT2 Cond Het and Nestin-ERT2 Cond KO 
P1 mice compared to controls.  There are no changes in primary neurosphere size in Ubc Cond 
Het (A), Nestin-ERT2 Cond Het (G) and Nestin-ERT2 Cond KO (G) mice compared to controls.  
Among primary neurospheres, those from Nestin-ERT2 Cond Het and Nestin-ERT2 Cond KO P1 
mice exhibit 22% and 40% reductions in neuronal potential, respectively, compared to controls 
(F,L).  Neuronal potential is reduced by 79% for Ubc Cond KO secondary neurospheres (F) and 
61% for Nestin-ERT2 Cond KO secondary neurospheres (L) compared to controls.  Neuronal 
potential of Ubc Cond Het primary and secondary neurospheres (C,F), Ubc Cond KO primary 
neurospheres (C) and Nestin-ERT2 Cond Het secondary neurospheres (L) are unchanged 
compared to controls.  Error bars in (A-L) indicate SEM (n=3 per genotype).  *p<0.05, **p<0.01, 





Figure 2.13 Loss of Chd7 results in reduced size of perinatal SVZ-derived neurospheres. 
(A-F) Representative images of primary and secondary neurospheres derived from SVZ of adult 
control (A,D), Ubc Cond Het (B,E) and Ubc Cond KO mice (C,F).  (G-L) Representative images 
of primary and secondary neurospheres derived from SVZ of adult control (G,J), Nestin Cond Het 





Figure 2.14: Modified retinoic acid signaling influences defects in Chd7-deficient neurospheres 
and semicircular canal development. 
(A-F) Secondary neurospheres were derived from P1 control, Nestin-ERT2 Cond Het and Nestin-
ERT2 Cond KO mice then treated with varying concentrations of all-trans retinoic acid (RA, 
A,B,E) or the retinoic acid signaling inhibitor citral (C,D,F), and assayed for changes in size, self-
renewal, and neuronal potential.  (A,B) Treatment with RA (0.1μM or 1μM) results in smaller 
neurospheres (A) and increased self-renewal (B) for all three genotypes.  (C,D) Treatment with 
citral (1μM or 10μM) in non-adherent neurosphere cultures causes increased Nestin-ERT2 Cond 
Het and Nestin-ERT2 Cond KO neurosphere size (C), and reduced self-renewal (D) for all three 
genotypes.  (E) Treatment of differentiating, adherent Nestin-ERT2 Cond KO neurospheres with 
1μM RA resulted in a 33% increase (from 39% to 72%) in the proportion of Nestin-ERT2 Cond 
KO TUJ1+ colonies compared to control TUJ1+ colonies.  (F) Neuronal potentials of Nestin-ERT2 
Cond KO differentiating neurospheres were unaffected by citral treatment.  (G-L) Pregnant 
females were untreated or treated with either RA by oral gavage or citral by intraperitoneal 
injection at E7.5, then embryos were extracted at E14.5 and processed for inner ear paint-filling.  
(G-I) Wild type embryos are unaffected by treatment with either RA or citral.  Chd7Gt/+ embryos 
consistently display lateral semicircular canal truncation (LC, denoted by white asterisk) in 
untreated conditions (J) which worsen with RA treatment (K) while treatment with citral results in 
rescue of the LC truncation in 29% (8/28 ears) of mutant inner ears (denoted by white arrowhead, 
L).  Error bars in (A-F) indicate SEM (n=3 per genotype).  Other abbreviations: ED: 




Figure 2.15 Inhibition of retinoic acid signaling by citral prevents semicircular canal defects in the 
developing Chd7-deficient inner ear. 
Pregnant females were treated with citral by intraperitoneal injection or retinoic acid by oral 
gavage at E7.5, then embryos were extracted at E14.5 and processed for inner ear paintfilling.  
29% (8/28 ears) of Chd7Gt/+ embryos showed wild type inner ear morphology and rescue of 
semicircular canal hypoplasia (n=18 wild type ears, n=28 Chd7Gt/+ ears). Retinoic acid treatment 
showed no effects on wild type inner ear morphology and did not rescue semicircular canal 





Figure 2.16 CHD7 binds to the promoters of retinoic acid receptor and pro-neuronal transcription 
factor genes and regulates their expression. 
(A) qRT-PCR analysis of total RNA from P1 control and Ubc Cond KO microdissected SVZ 
shows expression levels of Rarb, Rxrg, Neurod1, and Sox2. Threshold cycles are normalized to 
Gapdh.  In Ubc Cond KO P1 SVZ, expression levels of Rarb, Rxrg, and Neurod1 are decreased 
by 55-58% compared to controls.  Sox2 expression is unchanged in Ubc Cond KO SVZ 
compared to controls.  Black dashed line denotes control gene expression levels. (B-D) By ChIP-
qPCR, CHD7 is enriched relative to IgG at conserved regions 1, 2, 4, 6, and 8 for Rarb (B), 
conserved regions 1, 3, 4, and 6 for Rxrg (C), and conserved regions 1-4 for Neurod1 (D).  Non-
conserved regions are not enriched for CHD7 relative to IgG.  (E) Proposed model showing 
CHD7 function in neural progenitors, including regulation of Rarb, Rxrg, and pro-neuronal gene 
transcription and promotion of differentiation into neuroblasts.  Chd7-deficiency results in 
decreased Rarb, Rxrg, and pro-neuronal Neurod1 gene transcription leading to fewer neuroblasts 
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CHD7 regulates neuronal differentiation and maturation potentially through a 
complex with retinoic acid receptors. 
 
Introduction 
 Neural stem cell populations are responsible for the production of neurons 
that impart the remarkable functions of the mammalian brain.  While neural stem 
cell niches have been implicated in the development of the cortex, hippocampus, 
cerebellum and olfactory bulbs (OB), the exact cell type-specific gene expression 
patterns unique to these cells is currently poorly characterized.  Elucidating the 
molecular mechanisms behind the subventricular zone (SVZ) neural stem cell 
self-renewal and neurogenic defects observed in Chd7-deficient mice is 
imperative to understanding forebrain and OB malformations observed in 
CHARGE syndrome (Pinto et al. 2005; Legendre et al. 2012).   
The transcriptomes of neural stem and progenitor cells in the SVZ and 
neuroblasts populations in the rostral migratory stream (RMS) and OB have 
begun to be explored.  Notably, human neural stem cells express genes involved 
in several of the signaling pathways observed to be active in mouse neural stem 
cells including: retinoic acid metabolism enzymes, Wnt signaling molecules and 
growth factors (Marei et al. 2012).  SoxC transcription factors (SOX4, SOX11 and 
SOX12) are also highly expressed in human SVZ neural stem cells, which have 
recently been shown to be directly regulated by CHD7 and overexpression of 
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SoxC transcription factors rescues Chd7-deficiency in the adult SVZ (Feng et al. 
2013).   
 Laser capture microdissection of eGFP-expressing neuroblasts 
populations in the SVZ, RMS and OB followed by high throughput genetic 
analysis has demonstrated a remarkably elastic transcriptome for neuroblasts 
(Khodosevich et al. 2013).  Neuroblasts captured in the SVZ and caudal RMS 
show high expression of cell cycle regulators such as Ccnd2 (CyclinD2) and 
Cdk6 (Khodosevich et al. 2013).  As neuroblasts begin to move through the RMS 
and exit the cell cycle, genes responsible for neuronal migration and guidance 
become highly expressed including Dcx and Robo2 (Khodosevich et al. 2013).  
In the rostral RMS and OB, neuroblasts begin to differentiate into immature and 
mature neurons, concomitant with up-regulation of pro-neuronal transcription 
factors (Neurod1) and neurotransmitter receptors for GABAergic (Gabaara2, 
Gabaarb2, Gabaarb3 and Gabaarg2) and glutamatergic interneurons (Glua1, 
Glua2 and Glua4) (Khodosevich et al. 2013).  As shown in Chapter 2, loss of 
Chd7 in the mouse results in a significant decrease in DCX+ neuroblasts (Figs. 
2.5 and 2.6) without alteration of cell cycle genes (Fig. 2.11) (Micucci et al. 2013).  
These results indicate that CHD7 plays a major role in the cell fate of SVZ 
neuroblasts. 
 In order to thoroughly investigate changes in SVZ gene expression upon 
loss of Chd7, I performed whole genome microarray on microdissected SVZ 
tissue from postnatal day 1 (P1) control and ubiquitous conditional Chd7 
knockout mice to monitor for dysregulation of expression of key neural stem cell, 
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neural progenitor cell and neuroblasts genes.  Gene ontology (GO) analysis 
revealed CHD7 to regulate genes important for neurogenesis, neuronal 
differentiation, neuron maturation and retinoic acid signaling.  While high 
throughput methods for analyzing the transcriptome of SVZ cells generate large 
amounts of data from a very limited number of cells, biochemical analysis of 
cellular components responsible for neural stem and progenitor cell 
differentiation and cell fate is difficult due to the dearth of cells present in the 
perinatal and adult murine SVZ.  In order to circumvent this issue, I also utilized 
P19 embryonal carcinoma cells, a well characterized cell line which differentiates 
into neurons upon treatment with retinoic acid (McBurney 1993; Magnuson et al. 
1995; Soprano et al. 2007).  Use of P19 cells enabled me to examine for 
evidence of direct regulation of and interaction between CHD7 and retinoic acid 
receptors.  I also reduced Chd7 expression by short hairpin RNA (shRNA) 
transfection to determine changes in P19 cell growth and pro-neural gene 
expression.  My findings demonstrate that CHD7 is essential for proper neuronal 
differentiation, regulates pro-neural genes, and directly interacts with retinoic acid 
signaling. 
 
Materials and Methods 
Mouse strains, breeding and genotyping.   
Chd7flox/flox mice were maintained as previously described (Hurd et al. 
2007; Hurd et al. 2010).  Ubc-CreERT2 mice were maintained on a C57BL/6 
background and mated with Chd7flox/flox mice to generate Cre;Chd7flox/+ mice.  
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Cre;Chd7flox/+ mice were crossed to Chd7flox/flox to produce control (Chd7flox/+ and 
Chd7flox/flox), Chd7 conditional heterozygous (Cre;Chd7flox/+), and conditional 
knockout (Cre;Chd7flox/flox) mice.  Genomic DNA was isolated from tail and brain 
tissue and PCR genotyped as previously described (Hurd et al. 2010).  All 
procedures were approved by The University of Michigan University Committee 
on the Use and Care of Animals (UCUCA).  
 
Tamoxifen administration.  
Tamoxifen (Sigma-Aldritch, St. Louis, MO) was dissolved in sterile corn oil 
at a concentration of 10 mg/ml.  A single dose of Tamoxifen (0.2 mg/gbw) was 
administered by intraperitoneal injection to pregnant females at embryonic day 
15.5 and perinatal pups were processed for brain dissection.   
 
Microarray and gene ontology analysis.   
Subventricular zones from littermate control and Ubc Cond KO P1 mice (n 
= 4 per genotype) were microdissected and RNA was isolated using the 
RNAqueous-Micro RNA Isolation Kit (Ambion, Austin, TX, USA).  Isolated RNA 
was treated with DNase I prior to microarray and cDNA synthesis. For 
microarray, cDNA was prepared and amplified using the Ovation Pico WTA 
System V2 (Nugen Technologies, San Carlos, CA) then hybridized to a whole 
genome Mous Gene ST 1.1 strip array (Affymetrix, Santa Clara, CA).  Microarray 
data was quality controlled using a principal components analysis, analyzed in 
the affy, oligo, and limma packages of bioconductor implemented in the R 
statistical environment.  Expression values were calculated using a robust multi-
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array average.  Gene ontology analysis was performed by entering the list of up- 
and down-regulated genes from the microarray into the Gene Ontology Term 
Finder (Lewis-Sigler Institute for Integrative Genomics, Princeton University, 
http://go.princeton.edu/cgi-bin/GOTermFinder).   
 
Gene expression analysis. 
For quantitative real-time PCR, cDNA was generated using the 
Superscript First-Strand cDNA Synthesis system with random hexamers (Life 
Technologies).  Relative gene expression levels were assayed using TaqMan 
Gene Expression Master Mix and TaqMan probes (Applied Biosystems, Foster 
City, CA, USA) for Gapdh, Rara, Rarb, Rarg, Rxra, Rxrb, Rxrg, Tbr1 and Olig2 or 
SYBR Green Master Mix and SYBR Green probes (Applied Biosystems) for 
Gapdh, Chd7, Otx2, Bmp4 and Fgf10.  Each sample was run in triplicate using 
an Applied Biosystems StepOne-Plus Real-Time qPCR System.  The gene 
expression level of Gapdh was used as an internal, positive control.  The 
difference in threshold cycle (CT) between the assayed gene and Gapdh for any 
given sample was defined as the change in threshold cycle (ΔCT).  The 
difference in ΔCT between two samples was defined as ΔΔCT which represents a 
relative difference in expression of the assayed gene.  The fold change of the 
assayed gene relative to Gapdh was defined as 2-ΔΔCT.  Unpaired Student’s t-test 





P19 monolayer and neurosphere cultures. 
For undifferentiated monolayers, P19 embryonal carcinoma cells were 
passaged in MEMα (Life Technologies) + 10% FBS (Life Technologies) + 1X 
penicillin/streptomycin (Life Technologies).  For neurospheres, cells were 
passaged as monolayers, gently treated with 0.25% trypsin and plated on 0.7% 
agarose in bacterial culture plates in MEMα + 7.5% calf serum + 2.5% FBS + 1 
μM retinoic acid + 1X penicillin/streptomycin. Neurospheres were confirmed to 
form two days after plating by bright field microscopy and medium was changed 
two and four days after initial plating.  Six days after plating, neurospheres were 
collected by gentle centrifugation then prepared for experiments.   
 
Nuclear extract preparation. 
 Undifferentiated and neurosphere P19 cells were treated with 0.25% 
trypsin (Life Technologies) for 5 min at 37°C, triturated into a single cell 
suspension then centrifuged.  The cell pellets were rinsed twice with ice cold 1X 
PBS, resuspended in ice cold lysis buffer (15 mM HEPES, 10 mM KCl, 0.1 mM 
EDTA, 1 mM MgCl2, 350 mM sucrose, pH 7.4) and homogenized by passing the 
cells through a 1 mL syringe with a 26 3/8G needle.  The lysate was centrifuged, 
the supernatant (now called cytoplasmic extract 1) was removed and saved.  The 
pellet was resuspended in ice cold lysis buffer, gently vortexed to homogenize, 
centrifuged and the supernatant retained (cytoplasmic extract 2).  The process of 
resuspension and retention of the supernatant was repeated with nuclear lysis 
buffer (15 mM HEPES, 110 mM KCl, 250 mM NaCl, 0.1 mM EGTA, 5% glycerol, 
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pH 7.4) creating two nuclear extracts.  Extracts were used directly for 
immunoprecipitation experiments or flash frozen in liquid nitrogen and stored at -
80°C. 
 
Co-immunoprecipitation and Western blotting. 
 Cytoplasmic and nuclear extracts from undifferentiated and neurosphere 
P19 cells were pre-cleared with 20 μl Protein A/G agarose beads (Santa Cruz 
Biotechnology, Dallas, TX) for 1 hr by rotation at 4°C, centrifuged and 
supernatant removed to a new microfuge tube.  1 μg retinoic acid receptor 
antibody (RAR, Santa Cruz Biotechnology) was added to cytoplasmic and 
nuclear extracts and rotated overnight at 4°C in a cold room.  20 μl Protein A/G 
agarose beads were added to protein-antibody complexes and rotated for 2 hrs 
at 4°C.  The protein-antibody-bead complexes were washed in the following 
washing protocol: two low salt buffer washes (30 min per wash in 20mM Tris, 0.2 
mM EDTA, 10% glycerol, 0.1% NP-40, 150 mM KCl pH 7.9), two high salt buffer 
washes (30 min per wash in 20mM Tris, 0.2 mM EDTA, 10% glycerol, 0.1% NP-
40, 350 mM KCl pH 7.9) and two low salt buffer washes (30 min per wash).  The 
washed complexes were resuspended in 1X LDS loading buffer (Life 
Technologies) and heated at 75°C for 5 min.  10 μl of input and each 
immunoprecipitation condition were run on a 10% tris-glycine gel with MOPS 
buffer at 200V for 75 min.  The gel was placed in a NuPAGE transfer apparatus 
(Life Technologies) with two pieces of filter paper and a nitrocellulose membrane 
(Life Technologies) then transferred in 1X transfer buffer (Life Technologies) + 
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20% methanol overnight at 4°C.  The membrane was blocked overnight in 
blocking buffer (50 mM Tris, 150 mM NaCl, 0.05% Tween-20, 10% nonfat milk 
powder), washed three times for 5 min in TBST (50 mM Tris, 150 mM NaCl, 
0.05% Tween-20) and incubated overnight at 4°C with 1:1000 anti-CHD7 
antibody (Cell Signaling) in blocking buffer.  The membrane was washed three 
times for 5 min with TBST then incubated for 2 hrs at room temperature with 
1:500 goat anti-rabbit IgG HRP-conjugated secondary (Pierce Biotechnology, 
Rockford, IL).  The blot was then washed three times for 5 min with TBST and 
two times for 5 min with TBS, developed using SuperSignal West Pico 
Chemiluminescent system (Pierce Biotechnology) as per the manufacturer’s 
instructions and imaged using the FluorChem M MultiFluor System (Protein 
Simple, Santa Clara, CA). 
 
SIBR shRNA vectors and Chd7 knockdown. 
 pUI4-SIBR-GFP and pCS2-puro vectors were obtained from Drs. David 
Turner and Anne Vojtek (Yu et al. 2005; Chung et al. 2006; Taylor et al. 2008).  A 
concatemer of cDNA targeting exon 18  
(5’ AAAATCTACAGGCTGATTACAAGGAAC 3’) and exon 34  
(5’ ACTTCAAAGTTTATCTTGCCTAA 3’) of the mouse Chd7 gene were cloned 
into pUI4-SIBR-GFP.  Undifferentiated P19 cells were co-transfected with pCS2-
puro puromycin resistance vector and pUI4-SIBR-GFP containing either the 
Chd7 concatemer or a control sequence targeting luciferase using the TransIT-
LT1 transfection reagent (Mirus, Madison, WI) as per the manufacturer’s 
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instructions.  Transfected cells were selected with 10 μg/ml puromycin for three 
days, changing the medium as necessary to avoid an excess of dead cells then 
recovered for two days.  Selected cells were processed for RNA isolation and 
gene expression analysis as described above. 
 
P19 growth curves. 
 Undifferentiated P19 cells were transfected with pUI4-SIBR-GFP 
containing either the Chd7 concatemer or a control sequence targeting 




 Microarray analysis of Chd7-deficient SVZ suggests role for CHD7 in 
neuronal differentiation. 
 I sought to investigate changes in gene expression in the perinatal SVZ 
upon loss of Chd7.  I performed a whole mouse genome microarray using RNA 
isolated from the SVZ of control and Ubc Cond KO postnatal day 1 mice (n = 4 
per genotype).  The microarray identified 136 genes that were changed at least 
1.5 fold (117 genes down-regulated and 19 genes up-regulated) compared to 
controls (Tables 3.1 and 3.2).  The list of down-regulated genes was uploaded to 
the GO Term Finder to find broad classes of gene function for the genes 
changed upon loss of Chd7.  The most enriched GO terms were involved in 
neuronal differentiation (Rxrg, Rarb, Neurod1, Tbr1 and Eomes, also known as 
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Tbr2), neuron migration (Reln, Cdh8, Epha7 and Robo2) and synaptic 
transmission/action potentials (Gabra5, Grm3, Scn2a1, Grm5, Cacna1e and 
Gabrb1) (Table 3.3).  None of the up-regulated genes listed in Table 3.2 are 
currently implicated in SVZ neural stem cell niche development or function.  I 
also performed GO analysis on the list of up-regulated genes, but due to the 
small number of genes, no statistically significant terms were recovered.  
Interestingly, this microarray analysis showed that Rarb, Rxrg and 
Neurod1 were down-regulated in Chd7-deficient SVZ, thereby confirming our 
qRT-PCR and chromatin immunoprecipitation data for the down-regulation and 
CHD7 binding of Rarb, Rxrg and Neurod1 from Chapter 2 (Fig. 2.16) (Micucci et 
al. 2013).  The down-regulation of neuronal migration genes Reln, Cdh8, Epha7 
and Robo2 suggests that CHD7 may also play a role in guiding neuroblasts from 
the SVZ, through the RMS, and into the OB.  This hypothesis is bolstered by the 
paucity of DCX+ neuroblasts in the RMS of Chd7-deficient mice (Figs. 2.5 and 
2.6) (Micucci et al. 2013).  Of particular note is Robo2, a well-established axon 
guidance transmembrane receptor that binds the soluble Slit proteins and is 
highly expressed in migrating neuroblasts (Wu et al. 1999; Nguyen-Ba-Charvet et 
al. 2004).  Overall, these findings from the microarray analysis show that CHD7 
may be necessary for regulating expression of genes that promote migration of 
SVZ-derived neuroblasts through the RMS. 
Loss of Chd7 in the SVZ also led to reduced expression of mature 
neuronal genes involved in synaptic transmission and neurotransmitter receptor 
genes including GABA receptors (Gabra5 and Gabrb1), glutamate receptors 
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(Grm3 and Grm5) and ion channels (Scn2a1 and Cacna1e).  These classes of 
genes have been shown to be up-regulated in the transcriptome of neuroblasts in 
the rostral RMS and OB (Khodosevich et al. 2013).  Decreased expression of 
these neuronal maturation and integration genes underscores the reduction in 
mature OB interneurons observed in Chd7-deficient mice (Fig. 2.2) (Micucci et al. 
2013).  Reduction of Chd7 in the SVZ also enriched for GO terms for learning, 
memory, behavior and cognition.  While these GO terms are broad, they are 
reminiscent of cognitive and behavioral phenotypes associated with CHARGE 
syndrome (Hartshorne et al. 2005).   Additionally, CHD7 has recently been 
implicated as a gene involved in autism spectrum disorder, and may influence 
expression of genes involved in cognition and behavior (O'Roak et al. 2012; 
Jiang et al. 2013).  I conclude that loss of Chd7 in the perinatal SVZ leads to 
down-regulation of neuronal differentiation, migration and maturation genes, 
which may help explain the neurogenic defects, OB hypoplasia and anosmia 
observed in Chd7-deficient mice (Layman et al. 2009; Micucci et al. 2013). 
 
CHD7 shows isoform specificity in regulation of retinoic acid signaling. 
 Our previous studies have shown that modulation of retinoic acid signaling 
can partially rescue inner ear and SVZ neural stem cell phenotypes associated 
with Chd7-deficiency (Figs. 2.14-2.16) (Micucci et al. 2013).  In addition, I have 
shown that Rarb and Rxrg are down-regulated in the SVZ upon loss of Chd7 by 
qRT-PCR and microarray (Fig. 2.16 and Table 3.1).  In order to determine 
whether there is specificity for CHD7 regulation of retinoic acid and retinoid X 
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receptors, I performed qRT-PCR on all major isoforms of RAR (Rara, Rarb and 
Rarg) and RXR (Rxra, Rxrb and Rxrg).  Loss of Chd7 specifically reduced the 
expression of Rarb and Rxrg by 58% and 57%, respectively, but had no effect on 
the expression of Rara, Rarg, Rxra and Rxrb compared to control levels; thereby 
confirming the microarray results (Fig. 3.1A).   
Consistent with a reduction in the number of RMS neuroblasts in Chd7-
deficient mice (Figs. 2.3 and 2.5) and microarray analysis (Table 3.1), I found 
that expression of the neuroblast/immature neuron marker Tbr1 was decreased 
by 82% in Ubc  Cond KO SVZ compared to control. (Fig. 3.1A) (Micucci et al. 
2013).  I also investigated the expression level of Olig2, an important 
oligodendrocyte-lineage marker, due to the increase in GFAP+ glia present in 
Chd7-deficient mice (Figs 2.3 and 2.5) (Marshall et al. 2005; Micucci et al. 2013).  
Interestingly, Olig2 expression was unchanged in Ubc Cond KO P1 SVZ 
compared to control levels (Fig. 3.1A).  Unchanged Olig2 expression is not 
surprising for the early perinatal period, considering that gliogenesis occurs 
predominantly in the postnatal period.  While Olig2 expression is unchanged in 
the SVZ of perinatal Chd7-deficient mice, an increase in postnatal Olig2 
expression may explain why there is an expansion of glia observed in adult 
Chd7-deficient mice (Micucci et al. 2013).  These data show that CHD7 regulates 
expression of specific RAR and RXR genes and promotes pro-neural gene 
expression in neural progenitor cells and neuroblasts.   
 Prior studies showed by chromatin immunoprecipitation, qRT-PCR and 
microarray that CHD7 directly regulates the expression of Rarb and Rxrg (Fig. 
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2.16 and Table 3.1).  However, whether CHD7 physically associates with retinoic 
acid receptors in cells is unknown.  To address this, I performed co-
immunoprecipitation experiments for CHD7 and RAR’s using cytoplasmic and 
nuclear extracts from undifferentiated P19 cells and P19-derived neurospheres 
using a pan-RAR antibody that recognizes a common epitope for RARα, RARβ 
and RARγ, followed by western blotting using anti-CHD7 antibody.  In 
undifferentiated P19 cells, CHD7 was present in the nuclear fraction and 
excluded from the cytoplasmic extract, which is consistent with its role as a 
chromatin remodeling enzyme (Fig. 3.1B).  Interestingly, CHD7 binds RAR’s in 
the nucleus of both undifferentiated P19 cells and P19-derived neurospheres, but 
appears to be more enriched in undifferentiated cells (Fig. 3.1B).  These data 
demonstrate that CHD7 forms a complex with RAR’s in the nuclei of stem cell-
like and neuronal progenitor-like P19 cells.  While this co-immunoprecipitation 
experiment shows that CHD7 binds to RAR’s, the use of a pan-RAR antibody 
cannot distinguish whether CHD7 associates with specific RAR isoforms. 
 
CHD7 regulates gene expression and cell growth in P19 cells. 
 In order to more rigorously test the in vivo biochemical activity of CHD7, I 
developed shRNA vectors to specifically target the Chd7 transcript and ablate its 
translation into functional protein.  I cloned sequences from Exons 18 and 34 
from the mouse Chd7 gene into pUI4-SIBR-GFP, a vector that co-expresses 
GFP and the Chd7 shRNA from an intronic cassette based on the miR-155 
microRNA precursor (Fig. 3.2A) (Yu et al. 2005; Chung et al. 2006; Taylor et al. 
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2008).  Considering that Chd7 is known to play a role in the proliferation of 
olfactory epithelium and SVZ neural stem cells, the developing otocyst and SVZ-
derived neurospheres, I measured the effects of Chd7 shRNA on growth of 
undifferentiated P19 embryonal carcinoma cells (Layman et al. 2009; Feng et al. 
2013; Micucci et al. 2013).  P19 cells were transfected with the Chd7 shRNA 
construct or a control construct expressing a shRNA vector that targets 
luciferase, and cell number was assessed every 24 hrs for three days.  For Chd7 
shRNA transfections, there were 10% and 21% fewer P19 cells 48 hrs and 72 
hrs post-transfection, respectively, compared to control shRNA (Fig. 3.2B).  
There was no difference in cell number between Chd7 shRNA and control 
shRNA treated cells at 24 hrs (Fig. 3.2B).  These data are consistent with 28% 
fewer cells at 72 hrs post-transfection reported by Kita et al. in Chd7 shRNA 
transfected HeLa cells (Kita et al. 2012).   
Next, I confirmed knockdown of Chd7 and three genes known to be down-
regulated upon loss of Chd7 in the developing mouse (Otx2, Bmp4 and Fgf10) by 
qRT-PCR performed on total RNA from undifferentiated P19 cells that were co-
transfected with a puromycin resistance vector and Chd7 or control shRNA (Hurd 
et al. 2010).  Chd7 expression was reduced by 85% in Chd7 shRNA 
transfections compared to controls (Fig. 3.2C), which is significantly higher than 
the 25% knockdown observed by Kita et al. in Chd7 shRNA transfected HeLa 
cells (Kita et al. 2012).  Consistent with in situ hybridization experiments on 
embryonic inner ears, Chd7 shRNA transfection resulted in 72%, 77% and 51% 
reduction in expression of Otx2, Bmp4 and Fgf10, respectively, compared to 
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control shRNA (Fig. 3.2C) (Hurd et al. 2010).  Thus, our Chd7 shRNA constructs 
are effective at significantly reducing Chd7 mRNA levels and affect the 
expression of known CHD7 target genes.  The availability of Chd7 shRNA 
knockdown vectors allows for examination of Chd7 function in a well-described 
cell line that circumvents some of the limitations of biochemical analysis in 
primary SVZ neurospheres or tissue. 
 
Discussion 
 Here I showed that Chd7 deficiency in the perinatal SVZ results in down-
regulation of genes that facilitate retinoic acid signaling, neuronal differentiation, 
neuron migration and synaptic transmission.  Co-immunoprecipitation using P19 
embryonal carcinoma cell nuclear extract showed that CHD7 and at least one 
RAR directly bind and form a complex.  shRNA knockdown of Chd7 in P19 cells 
leads to decreased proliferation and reduced expression of known CHD7 target 
genes including Otx2, Bmp4 and Fgf10.  Together, these findings provide 
additional evidence that CHD7 regulates neuronal differentiation and maturation 
through the modulation of retinoic acid signaling. 
 Microarray analyses of neuroblast populations have demonstrated that 
these cells exhibit highly dynamic transcriptomes that change dependent upon 
their progression along the path from the SVZ to the OB (Khodosevich et al. 
2013).  Our microarray analysis of Chd7-deficient postnatal day 1 (P1) SVZ 
shows down-regulation of genes that are highly important for the identity 
(Neurod1, Tbr1 and Eomes), migration (Reln and Robo2) and maturation 
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(Gabra5, Grm3, Grm5 and Gabrb1) of neuroblasts.  CHD7 is known to bind 
poised enhancer elements of ectodermal lineage (Zentner et al. 2011) and 
through this mechanism may facilitate the resolution of pro-neural enhancers to 
promote neuronal differentiation and maturation in neuronal progenitor cells and 
neuroblasts.   
 CHD7 influences the transcription of cell fate and identity genes by 
forming cell type-specific complexes in mesenchymal stem cells (adipose vs. 
bone), neural crest cells (epithelium vs. mesenchyme) and neural stem cells 
(neuron vs. oligodendrocyte/glia) (Takada et al. 2007; Bajpai et al. 2010; Engelen 
et al. 2011; Micucci et al. 2013).  Here, I have shown that CHD7 is required for 
optimal transcription of Rarb and Rxrg by directly binding their promoters.  I also 
showed that CHD7 forms a complex with at least one RAR, although the specific 
isoform is not defined.  Further investigation is needed to determine whether (1) 
CHD7 binds only a single RAR or a specific RAR/RXR heterodimer, (2) the 
complex binds retinoic acid response elements (RARE) in promoters of known 
CHD7 target genes, and (3) the CHD7/RAR complex is specific for neural stem 
cells.  Considering the similarities between in utero retinoic acid deficiency and 
CHARGE syndrome (Mark et al. 2009; Janssen et al. 2012; Legendre et al. 
2012), exploration of the interaction of CHD7 and retinoic acid signaling 
components may prove vital for developing therapeutic and diagnostic 
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Table 3.1. Genes down-regulated in SVZ of Chd7-deficient neonatal mice by whole mouse 
genome microarray. 
 
Gene Description Fold Change 
Tac1 tachykinin 1 -3.68 
Reln reelin -2.53 
Gabra5 gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 -2.46 
Grm3 glutamate receptor, metabotropic 3 -2.35 
Cdh8 cadherin 8 -2.16 
Scn2a1 sodium channel, voltage-gated, type II, alpha 1 -2.16 
Grm5 glutamate receptor, metabotropic 5 -2.06 
Neurod1 neurogenic differentiation 1 -2.06 
Rxrg retinoid X receptor gamma -2.06 
Snca synuclein, alpha -1.99 
Tbr1 T-box brain gene 1 -1.93 
Rarb retinoic acid receptor, beta -1.91 
Eomes eomesodermin homolog (Xenopus laevis) -1.87 
Cntn1 contactin 1 -1.83 
Nefl neurofilament, light polypeptide -1.80 
Ppp1r1b protein phosphatase 1, regulatory (inhibitor) subunit 1B -1.79 
Dscam Down syndrome cell adhesion molecule -1.73 
Syt4 synaptotagmin IV -1.72 
Tnik TRAF2 and NCK interacting kinase -1.71 
Camk2b calcium/calmodulin-dependent protein kinase II, beta -1.68 
Lin7a lin-7 homolog A (C. elegans) -1.68 
Plcb1 phospholipase C, beta 1 -1.68 
Lingo1 leucine rich repeat and Ig domain containing 1 -1.65 
Slc17a6 solute carrier family 17, member 6 -1.65 
Grin2b glutamate receptor, ionotropic, NMDA2B (epsilon 2) -1.60 
Zic1 zinc finger protein of the cerebellum 1 -1.60 
Lrrc4c leucine rich repeat containing 4C -1.59 
Rapgef4 Rap guanine nucleotide exchange factor (GEF) 4 -1.59 
Cacna1e calcium channel, voltage-dependent, R type, alpha 1E subunit -1.57 
Gabrb2 gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 -1.57 
Pclo piccolo (presynaptic cytomatrix protein) -1.57 
Epha7 Eph receptor A7 -1.55 
Scg2 secretogranin II -1.55 
Adcy1 adenylate cyclase 1 -1.52 
Plk2 polo-like kinase 2 -1.52 




Table 3.2. Genes up-regulated in SVZ of Chd7-deficient neonatal mice by whole mouse genome 
microarray. 
 
Gene Description Fold Change 
Hspa8 heat shock protein 8 2.13 
Rsph4a radial spoke head 4 homolog A (Chlamydomonas) 1.75 
Serpina3n serine (or cysteine) peptidase inhibitor, clade A, member 3N 1.75 
Lhx6 LIM homeobox protein 6 1.71 
Lrp2 low density lipoprotein receptor-related protein 2 1.61 
Ccl3 chemokine (C-C motif) ligand 3 1.59 
Ogn osteoglycin 1.59 
Emp1 epithelial membrane protein 1 1.57 
Ndufs5 NADH dehydrogenase (ubiquinone) Fe-S protein 5 1.57 
Car5b carbonic anhydrase 5b, mitochondrial 1.55 
Gemin8 gem (nuclear organelle) associated protein 8 1.55 
Fbxo2 F-box protein 2 1.54 
Olfml3 olfactomedin-like 3 1.54 
Tspan15 tetraspanin 15 1.54 
Duxbl double homeobox B-like 1.53 
Hmox1 heme oxygenase (decycling) 1 1.53 
Afap1l2 actin filament associated protein 1-like 2 1.52 
Sfrp5 secreted frizzled-related sequence protein 5 1.52 




Table 3.3. Gene Ontology terms associated with genes down-regulated in SVZ of Chd7-deficient 
neonatal mice. 
 
Gene Ontology term Corrected P-value Genes annotated to GO term 
Transmission of nerve impulse 2.43e-8 
Gabrb2, Snca, Grm5, Pclo, Plk2, 
Reln, Camk2b, Cdh8, Lin7a, Scn2a1, 
Slc17a6, Rxrg, Syt4, Rapgef4, Grm3, 
Tac1, Grin2b, Cacna1e, Gabra5 
Synaptic transmission 4.46e-7 
Gabrb2, Snca, Grm5, Pclo, Plk2, 
Reln, Camk2b, Cdh8, Lin7a, 
Slc17a6, Syt4, Rapgef4, Grm3, 
Tac1, Grin2b, Gabra5 
Learning/Memory 8.25e-6 
Grm5, Adcy1, Plk2, Plcb1, Tac1, 
Reln, Grin2b, Cacna1e, Ppp1r1b, 
Gabra5 
Behavior 1.5e-5 
Snca, Scg2, Grm5, Adcy1, Plk2, 
Zic1, Plcb1, Dscam, Robo2, Cdh13, 
Tac1, Reln, Grin2b, Cacna1e, 
Ppp1r1b, Gabra5 
Cognition 1.55e-5 
Grm5, Adcy1, Plk2, Plcb1, Tac1, 
Reln, Grin2b, Cacna1e, Ppp1r1b, 
Gabra5 
Regulation of nervous system 
development 3.42e-5 
Lingo1, Grm5, Rapgef4, Lrrc4c, 
Dscam, Rxrg, Tbr1, Robo2, Reln, 
Neurod1, Nefl, Eomes, Camk2b, 
Tnik, Cntn1 
Regulation of neurogenesis 6.32e-5 
Lingo1, Grm5, Rapgef4, Lrrc4c, 
Dscam, Tbr1, Robo2, Reln, Neurod1, 
Nefl, Eomes, Camk2b, Cntn1, Tnik 
Nervous system development 1.4e-4 
Gabrb2, Neurod6, Lingo1, Grm5, 
Dscam, Reln, Nefl, Epha7, Eomes, 
Camk2b, Tnik, Cntn1, Scn2a1, 
Adcy1, Rapgef4, Lrrc4c, Zic1, Rxrg, 
Plcb1, Tbr1, Robo2, Neurod1, Rarb, 
Gabra5 
Regulation of transmission of nerve 
impulse 2.1e-4 
Snca, Grm5, Plk2, Rapgef4, Rxrg, 
Tac1, Reln, Grm3, Grin2b, Camk2b 
Regulation of cell projection organization 3.3e-4 
Rapgef4, Lrrc4c, Dscam, Tbr1, 
Robo2, Reln, Odz1, Nefl, Camk2b, 
Cntn1, Tnik 
Regulation of neuron differentiation 3.6e-4 
Rapgef4, Lrrc4c, Dscam, Tbr1, 
Robo2, Reln, Neurod1, Nefl, Eomes, 
Camk2b, Cntn1, Tnik 
Regulation of neurological system process 4.1e-4 Snca, Grm5, Plk2, Rapgef4, Rxrg, Tac1, Reln, Grm3, Grin2b, Camk2b 
Regulation of neuron projection 
development 4.9e-4 
Rapgef4, Lrrc4c, Dscam, Tbr1, 
Robo2, Reln, Nefl, Camk2b, Cntn1, 
Tnik 
Regulation of synaptic transmission 7.4e-4 Snca, Grm5, Plk2, Rapgef4, Tac1, Reln, Grm3, Grin2b, Camk2b 
Neurogenesis 8.5e-4 
Gabrb2, Lingo1, Grm5, Dscam, Reln, 
Nefl, Epha7, Eomes, Camk2b, Tnik, 
Cntn1, Adcy1, Lrrc4c, Rapgef4, 






Figure 3.1. CHD7 regulates retinoic acid receptor expression and interacts with retinoic acid 
receptors in vivo. 
(A) Quantitative RT-PCR on RNA isolated from SVZ of P1 control and Ubc Cond KO mice shows 
that loss of Chd7 specifically reduces expression of Rarb and Rxrg by 58% and 57%, 
respectively, while expression of Rara, Rarg, Rxra and Rxrb are unaffected.  Expression of Tbr1, 
a marker of neural progenitor cells, was decreased by 82%, while Olig2, an oligodendrocyte 
lineage marker, was unchanged at P1. (B) Co-immunoprecipitation was performed on 
undifferentiated (UD) and neurosphere (NS) P19 cells with anti-RAR antibody (recognizes RARα, 
RARβ and RARγ) followed by western blotting with anti-CHD7 antibody.  CHD7 was present in 
the nuclear fraction (N input) and absent from cytoplasmic extracts (C input) of undifferentiated 
P19 cells.  Anti-RAR immunoprecipitations performed with cytoplasmic extracts (C1, C2) of UD 
and NS P19 cells did not pull down CHD7, while CHD7 binds the nuclear RARs in both UD and 
NS P19 cells.  Black dashed line in (A) indicates control gene expression levels and error bars 





Figure 3.2.  Chd7 reduction leads to growth defects and decreased pro-neural gene expression. 
(A) Schematics showing the structure of the UI4-SIBR-GFP vectors containing either a single 
shRNA targeting Luciferase or a concatemer containing shRNAs targeting Chd7 exons 18 and 
34.  (B) Growth curves for control (white squares) and Chd7 shRNA (black diamonds) transfected 
undifferentiated P19 cells showed 17% fewer cells in Chd7 knockdown cells compared to control.    
(C) Undifferentiated P19 cells were transfected with vectors encoding a control or Chd7-specific 
shRNA, selected with puromycin, total RNA was isolated, converted to cDNA and used for SYBR 
Green qPCR for pro-neural genes.  Chd7 expression was reduced by 85%, confirming 
knockdown of Chd7.  Expression of Otx2, Bmp4 and Fgf10 was reduced by 72%, 77% and 51%, 
respectively, upon knockdown of Chd7.  Other abbreviations: ubC pro: human ubC promoter, 
GFP: green fluorescent protein, SV40 pA: SV40 polyadenylation sequence.  Error bars indicate 
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Analysis of Chd7 function during murine corticogenesis. 
 
Introduction 
The cerebral cortex of the mammalian brain is a complex, multilayered 
tissue that is responsible for processing sensory and motor inputs as well as 
mediating higher thought processes, language and memory.  In order to provide 
the proper input of external signals into sensory perception and output to the 
body, the cortex is stratified into layers of neurons that facilitate these activities.   
The intricate, layered development of the cortex arises from the neural stem cell 
niche lining the lateral ventricles (LV) of the mammalian forebrain known as the 
ventricular/subventricular zone (VZ/SVZ) (Lois et al. 1993; Davis et al. 1994).  
Early in corticogenesis (embryonic day 11 in the mouse embryo), VZ/SVZ neural 
stem cells divide symmetrically with a vertical cleavage plane to expand the 
existing stem cell pool (Smart 1973; Chenn et al. 1995).  As corticogenesis 
progresses, the neural stem cells switch to an asymmetric, horizontal cleavage 
pattern that produces a neural stem cell and a neural progenitor cell (Noctor et al. 
2004; Shitamukai et al. 2011).  Neural progenitor cells, also termed transit 
amplifying progenitors, rapidly divide symmetrically to produce more progenitor 
cells and asymmetrically to produce a large number of immature neurons (Noctor 
et al. 2008).  During this time, the transit amplifying cell population is responsible 
for the exponential increase in neuron production (Kriegstein et al. 2006).  It has 
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been hypothesized that the astronomical difference in the number of transit 
amplifying cells in the SVZ of the human cortex has led to the rapid evolution of 
higher thought processes present in humans as compared to other primates and 
mammals (Kriegstein et al. 2006).  
At embryonic day 15 in the developing mouse, the SVZ neural stem cell 
niche stops creating neurons destined for migration into the cortex and shifts to 
making neurons that migrate to the olfactory bulb (OB) (Wichterle et al. 2001; 
Lledo et al. 2008).  I have characterized the role of the chromatin remodeling 
enzyme CHD7 in the development and maintenance of the SVZ neural stem cell 
niche with regards to olfactory bulb development and maintenance (Micucci et al. 
2013).  Additionally, CHD7 is known to be required for proper development of the 
inner ear, nasal epithelium and eye, as evidenced by the high phenotypic 
penetrance of hearing, balance, olfaction and vision defects in individuals with 
CHARGE syndrome (Adams et al. 2007; Hurd et al. 2007; Layman et al. 2009; 
Hurd et al. 2010; Hurd et al. 2011).  In contrast, there has been no exploration of 
CHD7 function in the development of the cortex, which processes inputs from all 
of the affected sensory organs and may impact the sensory capabilities of 
CHARGE individuals.   
Chd7 is expressed in the embryonic mouse forebrain throughout the time 
period associated with active corticogenesis (embryonic day 11 to embryonic day 
15) (Hurd et al. 2007).  Here, I performed histological analyses of Chd7 in the 
mouse forebrain during mid and late corticogenesis (embryonic days 13 and 15).  
CHD7 co-localizes with neural stem cells and neural progenitor cells in the SVZ.  
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Immunofluorescence analysis of Chd7-deficient brains during corticogenesis 
showed that there are no defects in proliferation or apoptosis.  Neurosphere 
assays revealed that Chd7-deficiency resulted in a mild decrease in neurosphere 
size, but did not affect self-renewal or neuronal potential.  Our findings show that 
Chd7 is expressed during corticogenesis in neural stem and progenitor cells, but 
loss of Chd7 does not appear to affect the process in an appreciable manner. 
 
Materials and Methods 
Mouse strains, breeding and genotyping.   
Chd7flox/flox mice were maintained as previously described (Hurd et al. 
2007; Hurd et al. 2010).  Zsgreen Cre reporter mice (Madisen et al. 2010) were 
maintained on a C57BL/6/129 mixed background and bred with Chd7flox/flox to 
produce Zsgreen/Zsgreen; Chd7flox/flox mice.  Nestin-CreERT2 mice were 
maintained on a C57BL/6 background and mated with Chd7flox/flox  or 
Zsgreen/Zsgreen; Chd7flox/flox  mice to generate Cre;Chd7flox/+ mice.  
Cre;Chd7flox/+ mice were crossed to Chd7flox/flox to produce control (Chd7flox/+ and 
Chd7flox/flox), Chd7 conditional heterozygous (Cre;Chd7flox/+), and conditional 
knockout (Cre;Chd7flox/flox) mice.  Genomic DNA was isolated from tail and brain 
tissue and PCR genotyped as previously described (Hurd et al. 2010).  All 
procedures were approved by The University of Michigan University Committee 





Tamoxifen administration.  
Tamoxifen (Sigma-Aldritch, St. Louis, MO) was dissolved in sterile corn oil 
at a concentration of 10 mg/ml.  A single dose of Tamoxifen (0.2 mg/gbw) was 
administered by intraperitoneal injection to pregnant females at embryonic day 
11.5 (E11.5) and embryos were processed for cryosectioning (at E13.5 and at 
E15.5) or neurosphere assays (at E14.5). 
 
Histology and embedding.   
E13.5 and E15.5 embryos were placed in 4% paraformaldehyde for 2 hrs, 
then cryoprotected in 30% sucrose, embedded in OCT (Tissue Tek, Torrance, 
CA), frozen and sectioned at 12 µm.   
 
Immunofluorescence.   
Cryosections from E13.5 and E15.5 embryos (n = 3 per genotype) were 
processed for immunofluorescence with antibodies against CHD7 (1:7500; Cell 
Signaling Technology, Beverly, MA), cleaved caspase 3 (1:800, Cell Signaling 
Technology), phospho-histone H3 (1:500, EMD Millipore), Nestin (1:500, 
Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA), 
SOX2 (1:250; EMD Millipore), PAX6 (1:300, Covance, Princeton, NJ), TBR2 
(1:2000, a gift from Robert Hevner), GFAP (1:500; Sigma), O4 (1:800; 
Developmental Studies Hybridoma Bank), Tuj1 (1:400; Covance). All secondary 
antibodies were used at 1:200 with Alexa Fluor 488, Alexa Fluor 555 or 
biotinylated secondary antibodies (Vector Laboratories) conjugated with 
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streptavidin-Horseradish Peroxidase and Alexa Fluor 488 Tyramide Signal 
Amplification or Alexa Fluor 555 Tyramide Signal Amplification (Life 
Technologies, Carlsbad, CA).  Images were produced by single channel 
fluorescence microscopy on a Leica upright DMRB microscope (Leica Camera 
AG, Solms, Germany) and processed in Photoshop CS5.1 (Adobe, San Jose, 
CA). 
 
SVZ proliferation and apoptosis studies.   
E13.5 and E15.5 embryos (n = 3 per genotype) were processed for 
immunofluorescence with antibodies against phospho-histone H3 and cleaved 
caspase 3.  Images were captured by single channel fluorescence microscopy on 
a Leica upright DMRB microscope and processed in Adobe Photoshop CS5.1.  
For quantification of pH3+ and caspase3+ cells, 12 images using the 10X (pH3) 
or 20X (caspase3) objective lens were taken of six SVZ sections per genotype 
and the number of pH3+ and caspase3+ cells were counted using the cell 
counter function of Image J (National Institutes of Health, Bethesda, MD).   
 
Neurosphere cultures.  
E14.5 embryos (n = 2 per genotype) were decapitated, skin was removed 
from the brain, the entire forebrain was dissected and dissociated in 
trypsin/EDTA (Life Technologies) and counted on a hemacytometer.  For primary 
neurosphere formation assays, 1000 cells were plated on ultra-low binding 6 well 
plates (Corning, Corning, NY) under self-renewal conditions (media with EGF 
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and FGF), incubated at 37°C with 6.5% CO2 for 8 days then measured and 
imaged using an Olympus IX81 motorized inverted microscope (Olympus, Tokyo, 
Japan).  Secondary neurospheres were generated by dissociating single primary 
neurospheres and re-plating them under self-renewing conditions.  For 
differentiation, single secondary neurospheres were plated under adherent 
conditions with FGF and without EGF (24 well tissue culture-treated plates 
(Corning) with poly-D-lysine and human fibronectin (Biomedical Technologies, 
Stoughton, MA)) then incubated at 37°C with 6.5% CO2 for 12 days.  
Neurosphere diameter (n=150 per genotype) was measured using the arbitrary 
line tool in the Olympus cellSens Dimension software package.  Neurosphere 
frequency was determined by counting the total number of neurospheres greater 
than 50 µm in diameter in each well of a 6 well plate and dividing by the total 
number of cells plated per well.  Statistical significance was determined by 
unpaired Student’s t-test.  
 
Neurosphere differentiation, staining and scoring.   
Secondary neurospheres were differentiated as described above then 
treated with 1:800 anti-O4 antibody for 1 hr and fixed with ice cold 95% ethanol/ 
5% glacial acetic acid at -20ºC for 20 min.  Fixed neurospheres were blocked for 
1 h at room temperature with light rocking with blocking buffer (0.05% 
octylphenoxypolyethoxyethanol (NP-40, Sigma), 2 mg/ml bovine serum albumin 
(Sigma) in phosphate buffered saline).  Alexa Fluor 647 conjugated goat anti-
mouse IgM (1:500, Life Technologies) diluted in blocking buffer was added to 
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each well and incubated at room temperature for 1 h with light rocking.  Each well 
was washed three times with blocking buffer then a cocktail of 1:500 anti-Tuj1 
and 1:500 anti-GFAP primary antibodies was added to each well and incubated 
at room temperature for 1 h with light rocking.  Each well was washed three times 
with blocking buffer then incubated in a cocktail of 1:500 Alexa Fluor 555 goat 
anti-mouse IgG2a and 1:500 Alexa Fluor 488 goat anti-mouse IgG1 at room 
temperature for 1 hr with light rocking.  Each well was washed three times and 
nuclei were stained with 1:1000 DAPI for 15 min.  Stained colonies were imaged 
with an Olympus IX81 motorized inverted microscope and scored for the 
presence or absence of cell type-specific immunofluorescence (n = 12 
neurospheres per genotype).  Statistical significance was determined by 
unpaired Student’s t-test.  
 
Retinoic acid and citral treatment of neurosphere cultures. 
 Neurosphere assays were performed as above on control, Nestin-ERT2 
Cond Het, and Nestin-ERT2 Cond KO P1 mice.  Secondary neurospheres (n = 2 
per genotype) were plated in ultra-low binding 6 well plates in self-renewal 
medium or medium supplemented with 0.1 μM retinoic acid (Sigma), 1 μM 
retinoic acid, or 10 μM citral (Sigma) (n = 12 wells per genotype).  For 
differentiation, untreated secondary neurospheres from each genotype were 
plated in 24 well plates in differentiation medium or medium supplemented with 1 
μM retinoic acid, 1 μM citral, or 10 μM citral (n = 12 neurospheres per condition), 




Chd7 is expressed in SVZ neural stem and progenitor cells during peak 
corticogenesis. 
 Chd7 is expressed throughout the mouse forebrain during embryogenesis 
(Hurd et al. 2007), but its cell type-specific co-localization during corticogenesis is 
currently unknown.  To address this, I performed co-immunofluorescence for 
CHD7 and cell type-specific markers on coronal forebrain sections from wild type 
embryonic day 13.5 (E13.5) mouse embryos (Fig. 4.1B).  CHD7 co-localizes with 
a subset of Nestin+ neural stem cells (Fig. 4.1C) and SOX2+ neural stem and 
progenitor cells (Fig. 4.1D) in the VZ/SVZ along the lateral wall of the LV.  
Additionally, CHD7 is present in PAX6+ and TBR2+ neural progenitor cells in the 
SVZ of wild type E13.5 embryos (Fig. 4.1E,F).  These data are consistent with 
Chd7 expression in neural stem and progenitor cells in the adult mouse SVZ 
(Fig. 2.4) and suggest that CHD7 may play a role in SVZ development and 
maintenance throughout life (Feng et al. 2013; Micucci et al. 2013).   
In order to assess for potential defects in cortex development due to loss 
of Chd7, I utilized the Nestin-CreERT2 allele and the Zsgreen reporter to 
conditionally knockout Chd7 expression specifically in neural stem cells at the 
onset of corticogenesis at E11.5 and to mark cells in which recombination of the 
Chd7flox allele has occurred (Fig. 4.1A) (Ables et al. 2010; Madisen et al. 2010).  
Chd7 is expressed throughout the E13.5 SVZ (Fig. 4.1G) and is absent in 
embryos with neural stem cell-specific Chd7 conditional deletion (NestinERT2 
Cond KO, Fig. 4.1H).  Activation of the Zsgreen reporter, combined with loss of 
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CHD7 immunofluorescence, confirms Nestin-CreERT2 specific deletion of Chd7 
in the NestinERT2 Cond KO embryonic SVZ (Fig. 4.1H). 
 
Chd7-deficiency does not affect proliferation or apoptosis in the SVZ 
during mid-corticogenesis. 
 In studies outlined in Chapter 2, I examined the cortical thickness of adult 
Nestin-Cre conditional Chd7 knockout mice, in which Chd7 is deleted in Nestin 
lineage cells beginning at E8.5.  Cortical thickness was used in this context as a 
measure of cumulative SVZ proliferation and neuronal migration during 
development and into adulthood.  While I did not observe any changes in cortical 
thickness in Nestin Cond KO adult mice compared to controls (Fig. 2.7), the 
possibility remains that the crude measurement of cortical thickness may have 
masked a minor defect during a brief proliferative or migratory window during 
embryogenesis.  In order to investigate this, I analyzed the E13.5 Chd7-deficient 
mouse SVZ for changes in cell proliferation that may arise due to Chd7-
deficiency.  Immunofluorescence detecting phosphorylated histone H3 (pH3), a 
marker of mitotic cells, revealed no changes in SVZ proliferation between control 
and NestinERT2 Cond KO embryos (Fig. 4.2A-C).  I also observed no changes in 
cellular apoptosis, marked by cleaved caspase3 (casp3), between control and 
NestinERT2 Cond KO SVZ at E13.5 (Fig. 4.2D-F).  While I did not observe 
proliferation or apoptosis defects between E11.5 and E13.5, these data leave 
open the possibility that CHD7 function may be more critical during later 




Loss of Chd7 results in minor neurosphere size deficits while having no 
impact on self-renewal or neurogenesis. 
 In order to detect more subtle effects of Chd7-deficiency on stem and 
progenitor cell function, I performed neurosphere assays using control, 
NestinERT2 Cond Het and NestinERT2 Cond KO E14.5 embryonic forebrains 
(Fig. 4.3A) (Reynolds et al. 1992; Pastrana et al. 2011).  Similar to perinatal and 
adult neurosphere analyses (Fig. 2.8 and 2.12), NestinERT2 Cond Het and 
NestinERT2 Cond KO showed a decrease in neurosphere size by 12% and 23%, 
respectively, compared to controls (Fig. 4.3B).  Treatment with retinoic acid (RA) 
led to a reduction in neurosphere size regardless of genotype (Fig. 4.3B).  The 
dosage dependent differences in neurosphere size observed among untreated 
controls, NestinERT2 Cond Het and NestinERT2 Cond KO neurospheres was 
preserved upon treatment with RA (Fig. 4.3B).  Consistent with data obtained 
from citral-treated perinatal neurospheres (Fig. 2.14), inhibition of RA signaling 
resulted in a rescue of the size defect of NestinERT2 Cond Het and NestinERT2 
Cond KO neurospheres which were only 2% and 4% smaller, respectively, 
compared citral-treated controls (Fig. 4.3B).  These data show that there is a 
mild, but significant, proliferative defect in Chd7-deficient SVZ neural stem cells 
during corticogenesis that can be rescued by modulating RA signaling. 
Chd7-deficient neurospheres derived from E14.5 forebrain did not display 
self-renewal or neurogenic defects (Figs. 4.3C,D). Additionally, modulation of 
retinoic acid signaling did not affect E14.5 SVZ neurosphere self-renewal and 
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differentiation (Figs. 4.3C,D).  These data suggest that Chd7 may be largely 
unnecessary for self-renewal and neuronal differentiation during corticogenesis.  
Conversely, using whole forebrain for neurosphere assays may mask any effects 
that may be observed if microdissected VZ/SVZ were used as the starting 
material.   
 
Chd7 expression persists during late corticogenesis, but Chd7 deficiency 
exerts no effects on SVZ proliferation. 
Corticogenesis proceeds in the mouse from E11 to E15.  To test whether 
CHD7 regulates later aspects of cortex formation, I assayed CHD7 co-
localization with neural stem and progenitor cell markers persisted at E15.5, 
immediately prior to the transition from cortical neurogenesis to olfactory bulb 
neurogenesis (Wichterle et al. 2001) (Fig. 4.4B).  As observed at E13.5, CHD7 
co-localizes with Nestin+ neural stem cells, SOX2+ neural stem and progenitor 
cells and TBR2+ neural progenitor cells at E15.5 (Fig. 4.4C-E).   
Next, I generated E15.5 NestinERT2 Cond KO embryos to address 
whether there is a proliferation defect present between E13.5 and E15.5 which 
would have been missed in E13.5 studies detailed above (Fig. 4.4A).  I observed 
no differences in pH3 staining between control and NestinERT2 Cond KO E15.5 
SVZ corticogenesis period (Fig. 4.4F-H).  Additionally, there were no detectable 
Caspase 3+ cells observed in control and NestinERT2 Cond KO E15.5 SVZ. 
These data imply that there is no appreciable change in SVZ proliferation or 
apoptosis with loss of Chd7 throughout the corticogenic period, but do not 
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investigate the possibility of CHD7 activity in neuroblast migration and maturation 
which may impact cortex function.   
 
Discussion 
 Here I showed that Chd7 is expressed in neural stem and progenitor cells 
during mid (E13.5) and late (E15.5) corticogenesis.  Loss of Chd7 through mid-
corticogenesis (E11.5-E13.5) or late corticogenesis (E11.5-E15.5) did not result 
in changes in proliferation and apoptosis.  Conversely, E14.5 Chd7-deficient 
neurospheres displayed a 23% reduction in size that is rescued with inhibition of 
retinoic acid signaling through citral treatment, but did not have self-renewal or 
neuronal differentiation deficits.  Together, these findings demonstrate that Chd7 
is not required for the proper function of the SVZ neural stem cell niche during 
corticogenesis. 
 While there does not appear to be any aberration in neural stem and 
progenitor cell self-renewal or proliferation upon loss of Chd7 during cortex 
formation, I did not characterize CHD7 function in the neuroblasts produced by 
neural progenitor cells or to the identity of cortical neuron layers.  CHD7 could 
potentially play a role in the migration and maturation of neurons, as suggested 
by changes in expression of key neuronal migration genes in perinatal SVZ from 
Chd7 mutant mice (Table 3.1).  Analysis of the fate of Chd7-deficient neuroblasts 
born in the SVZ during corticogenesis may provide insights into the 
differentiation, migration and maturation of these neuron populations.  Cortical 
neuron migration or maturation phenotypes in Chd7-deficient mice may indicate 
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a potential reason for further complication of sensory processing in CHARGE 
individuals.   
CHD7 has been implicated in autism spectrum disorder (ASD), and the R 
in the CHARGE syndrome acronym originally represented mental retardation 
(Fernell et al. 1999; O'Roak et al. 2012). However, cognitive deficiencies 
observed in CHARGE individuals may be more related to extreme sensory 
impairment and difficulties in learning and communication than isolated 
intellectual disability (Hartshorne et al. 2005).  Interestingly, Chd7 is highly 
expressed in the neural stem cell niche of the dentate gyrus of the hippocampus, 
the region of the brain responsible for learning and memory (Feng et al. 2013).  
Preliminary studies of CHD7 function in the dentate gyrus indicate that CHD7 
regulates production of neuroblasts, as well as neuronal differentiation and 
maturation (Feng et al. 2013).  Further studies investigating the role of CHD7 in 
the function of the sensory cortex and hippocampus are clearly needed to inform 
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Figure 4.1. CHD7 co-localizes with neural stem and progenitor cells during early corticogenesis. 
(A) Schematic showing the Tamoxifen dosing regimen where pregnant females received a single 
intraperitoneal injection of Tamoxifen (0.2 mg/gbw) at embryonic day 11.5 (E11.5) and embryos 
were harvested for cryosectioning at E13.5.  (B) Cartoon showing a coronal section of an E13.5 
mouse forebrain showing the neural stem and progenitor cells in the ventricular/subventricular 
zones (VZ/SVZ, gray) lining the lateral ventricles (LV, black) with the orange box denoting the 
region shown in C-H.  CHD7 co-localizes with the neural stem cell markers Nestin (C) and SOX2 
(D) and the neural progenitor cell markers PAX6 (E) and TBR2 (F).  The Zsgreen reporter was 
used to monitor deletion of Chd7 in Nestin-lineage cells, also confirmed by CHD7 
immunofluorescence in NestinERT2 Cond KO E13.5 SVZ (H) compared to controls (G). White 
arrows denote co-localized yellow cells.  Other abbreviations: Ctx: cortex. Scale bars in (C): 25 





Figure 4.2.  Proliferation and apoptosis are normal in Chd7-deficient SVZ during early 
corticogenesis. 
Coronal cryosections of E13.5 SVZ from control and NestinERT2 Cond KO embryos were 
processed for immunofluorescence for phospho-histone H3, marking mitotic cells (pH3, A,B) and 
cleaved caspase3, marking apoptotic cells (casp3, C,D).    There was no difference in the number 
of pH3+ cells between control (A) and NestinERT2 Cond KO (B) E13.5 SVZ (quantified in C).  In 
addition, there was no difference in the number of casp3+ cells between control (D) and 
NestinERT2 Cond KO (E) E13.5 SVZ (quantified in F).  Other abbreviations: LV: lateral ventricles.  
Scale bars in (A,B): 250 μm and (D,E): 25 μm.  Error bars in (C, F) indicate standard error of the 





Figure 4.3.  Chd7-deficient forebrain neurospheres display mild proliferative defects. 
(A)  Schematic showing the Tamoxifen dosing regimen where pregnant females received a single 
intraperitoneal injection of Tamoxifen (0.2 mg/gbw) at embryonic day 11.5 (E11.5) and embryos 
were harvested for neurosphere assays at E14.5.  Secondary neurospheres were derived from 
P1 control, Nestin-ERT2 Cond Het and Nestin-ERT2 Cond KO mice then treated with varying 
concentrations of all-trans retinoic acid (RA) or the retinoic acid signaling inhibitor citral and 
assayed for changes in size (B), self-renewal (C), and neuronal potential (D).  (B) Untreated 
neurospheres displayed a Chd7 dosage dependent reduction in size, while treatment with 1μM 
RA resulted in slightly smaller control and NestinERT2 Cond Het neurospheres and treatment 
with 1μM citral rescued Nestin-ERT2 Cond Het and Nestin-ERT2 Cond KO neurosphere size to 
control levels.  (C) There were no discernible changes in self-renewal of E14.5 secondary 
neurospheres with Chd7-deficiency or alterations of retinoic acid signaling. 
(D) Neuronal potentials of E14.5 NestinERT2 Cond KO secondary neurospheres, regardless of 
treatment, were also unchanged compared to control.  Error bars in (B-D) indicate SEM (n=2 per 





Figure 4.4. CHD7 is expressed in E15.5 SVZ neural stem and progenitor cells and does not 
regulate proliferation. 
(A) Schematic showing the Tamoxifen dosing regimen where pregnant females received a single 
intraperitoneal injection of Tamoxifen (0.2 mg/gbw) at embryonic day 11.5 (E11.5) and embryos 
were harvested for cryosectioning at E15.5.  (B) Cartoon showing a coronal section of an E15.5 
mouse forebrain showing the neural stem and progenitor cells in the ventricular/subventricular 
zones (VZ/SVZ, gray) lining the lateral ventricles (LV, black) with the orange box denoting the 
region shown in C-E.  CHD7 co-localizes with the neural stem cell markers Nestin (C) and SOX2 
(D) and the neural progenitor cell marker TBR2 (E).  There was no difference in the number of 
pH3+ cells between control (F) and NestinERT2 Cond KO (G) E13.5 SVZ (quantified in H).  White 
arrows denote co-localized yellow cells.  Other abbreviations: Ctx: cortex.  Scale bars in (C-E): 25 
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Conclusions and Future Directions 
Summary 
 The focus of my thesis work has been to explore the role of CHD7 in the 
regulation of neural stem cells and their progeny from embryonic development 
into adulthood.  Specifically, I have focused on the subventricular zone (SVZ) 
neural stem cell niche which creates neurons that populate the olfactory bulbs 
(OB) and cerebral cortex.  While these two regions vary greatly in their functions 
in the mature brain, they are vital to the survival and function of most mammals.  
Human olfaction and processing of olfactory signals through the olfactory bulbs is 
vital to daily life (Lledo et al. 2006; Lledo et al. 2008).  The cerebral cortex is the 
processing center for sensory, motor and cognitive information and its evolution 
has imbued higher mammals with sentience (Kriegstein et al. 2006).  In 
CHARGE individuals with CHD7 mutations, olfactory, motor and cognitive 
phenotypes may be caused by defects in neural stem cell function during 
embryogenesis and throughout life (Hartshorne et al. 2005; Issekutz et al. 2005; 
Legendre et al. 2012). 
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CHD7 in the perinatal and adult SVZ 
Conclusions 
 In Chapter 2, I developed a mouse model of Chd7-deficiency in the adult 
and perinatal brain to investigate the role of Chd7 in the maintenance and 
development of the SVZ.  I found that adult Chd7 heterozygous mice have 
reduced numbers of GABAergic and dopaminergic interneurons which are 
responsible for modulating olfactory signals to the olfactory cortex.  This finding 
led me to observe Chd7 expression from the neural stem cell niche in the SVZ, 
through the rostral migratory stream (RMS) and into the OB.  Double 
immunofluorescence experiments with cell type specific markers showed that 
CHD7 co-localizes with a subset of neural stem cells, with the majority of neural 
progenitor cells and neuroblasts and with subsets of mature GABAergic and 
dopaminergic interneurons.  In both adult and newborn SVZ, in vivo 
immunofluorescence and in vitro neurosphere assays demonstrated that Chd7-
deficient neural stem and progenitor cells display proliferative and neurogenic 
defects.  I also observed a drastic reduction in neuroblasts in the adult RMS of 
Chd7-deficient mice and a corresponding increase in glial cells indicating a 
potential cell fate switch.  Interestingly, modulation of retinoic acid signaling was 
able to partially rescue the proliferative and neurogenic defects observed in 
perinatal neurospheres upon loss of Chd7.  I confirmed direct regulation of 
retinoic acid signaling by chromatin immunoprecipitation which showed CHD7 
binding to the promoter elements of retinoic acid receptor genes.  Overall, I have 
demonstrated that Chd7 is necessary for the proper function of the perinatal and 
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adult SVZ neural stem cell niche and its progeny.  These studies are an 
important link to understanding the affected molecular mechanisms in Chd7-
deficienct neural stem cell niches that may lead to some of the neurological 
phenotypes observed in CHARGE syndrome. 
 
Future Directions 
 CHD7 is intimately tied to cell fate decisions in stem cells (Takada et al. 
2007; Bajpai et al. 2010; Engelen et al. 2011; Feng et al. 2013) and our data 
suggest an important role for CHD7 regulation of the choice between neuronal 
cell fate and oligodendrocyte or glial cell fate in SVZ neural stem and progenitor 
cells (Micucci et al. 2013).  Additionally, CHD7 binds to poised promoter and 
enhancer elements of ectodermal lineage genes (Zentner et al. 2011).  Taken 
together, it can be hypothesized that CHD7 binds to poised genetic elements of 
pro-neuronal genes (such as Ascl1, Tbr2, Tbr1 and Neurod1), recruits histone 
modifying enzymes such as H3K4 methyltransferases and activates transcription 
as neural stem and progenitor cells adopt a neuronal fate.  This hypothesis could 
be tested by chromatin immunoprecipitation followed by massively parallel 
sequencing (ChIP-seq) in mouse or cell models of Chd7-deficiency.  Chromatin 
preparations from wild type perinatal or adult mouse SVZ or P19 embryonal 
carcinoma neurospheres (McBurney et al. 1988; McBurney 1993; MacPherson et 
al. 1997) could be processed for immunoprecipitation with anti-CHD7 antibody, 
activating histone modifications (H3K4me1, H3K4me3, H3K27ac) or repressing 
histone modifications (H3K9me3, H3K27me3).  Results of these experiments 
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would establish a baseline of CHD7 genomic binding in neural stem cells and its 
association with active, poised and repressed gene transcription, thereby 
creating a map of CHD7 binding in neural stem cells.  Additionally, CHD7 ChIP-
seq performed in neural stem cells would provide vital insight into the genomic 
binding properties of CHD7.  For example, CHD7 may co-localize with SOX 
family consensus binding sequences or retinoic acid response elements (RARE).  
This binding information would be helpful in determining whether CHD7 is 
regulating pro-neural gene expression either through regulation of expression of 
retinoic acid signaling mediators or direct interaction with retinoic acid receptors 
at pro-neural target genes with RARE’s.   
 An interesting extension of these ChIP-seq experiments would be to 
induce loss of Chd7 expression, either through Cre recombination of the Chd7flox 
allele in vivo (Hurd et al. 2010) or transfection with a Chd7 shRNA vector in vitro 
(Yu et al. 2005) then monitor changes in chromatin modifications in known 
CHD7-bound genes.  Upon loss of Chd7, formerly activated pro-neural genes 
may become poised or repressed, potentially leading to an inability to 
differentiate into neuronal cell types.  Considering that I have observed a loss of 
neuronal differentiation and an increase in glia in the adult Chd7-deficient mouse 
(Micucci et al. 2013), it is necessary to know whether the promoter or enhancer 
status at gliogenic genes such as Olig2 or Gfap changed from repressed to 
poised or active in neural stem cells upon loss of Chd7.  Quantitative RT-PCR 
could be used to monitor for increases or decreases in gene expression between 
control and Chd7-deficient neural stem cells consistent with changes in promoter 
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or enhancer status.  One would predict that since there is a significant increase in 
the amount of glial staining in the SVZ, RMS and OB of Chd7-deficient mice, 
there would be a deposition of activating histone marks at pro-glial genes and a 
corresponding increase in pro-glial gene expression.   Overall, these experiments 
could provide mechanistic insight into the direct regulation of pro-neural genes in 
neural stem cells by CHD7 through modulation of histone modifications at 
promoter or enhancer elements. 
 While ChIP-seq experiments designed to observe the co-localization of 
CHD7 and various histone methylation marks at promoter and enhancer 
elements would provide important insight into the genomic location of CHD7 in 
neural stem cells, these experiments do not determine whether CHD7 is 
physically interacting with and resolving chromatin structures where these 
methylation marks are present.  Bouazoune and Kingston have published the 
catalytic and chromatin remodeling activity of many recombinant CHD7 mutants 
(Bouazoune et al. 2012).  Recombinant CHD7 containing CHARGE individual-
observed missense mutations in the chromodomains show significant reductions 
in ATP hydrolysis and disruption of DNA-histone contacts (Bouazoune et al. 
2012).  To expand upon these studies by Bouazoune and Kingston and those 
proposed above, it is necessary to investigate the substrate specificity of the 
CHD7 chromodomains to determine the true physiologically relevant binding 
event between CHD7 and methylated histones at promoter and enhancer 
elements.  In order to determine CHD7 chromodomain specificity, isothermal 
titration calorimetry (Ghai et al. 2012) would be performed with wild type or 
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chromodomain-mutant CHD7 (S834F, K907T and T917M) (Delahaye et al. 2007; 
Bartels et al. 2010) and covalently-modified, recombinant nucleosomes 
containing activating (H3K4me1, H3K4me3) or repressing (H3K9me3, H3K27me) 
histone marks.  An appropriate control for these experiments would be 
unmodified recombinant histones or HeLA-purified nucleosomes to determine the 
level of non-specific binding.  Considering the role of CHD7 in promoting gene 
expression and ChIP-seq data indicating that CHD7 specifically binds chromatin 
regions with H3K4me1, one would predict that CHD7 would most tightly bind to 
activating histone methylation marks and bind weakly or not at all to repressive 
histone methylation marks.  These experiments would provide important clues as 
to the biochemically relevant substrate for CHD7 function and determine whether 
the co-localization of CHD7 with poised and active chromatin is a direct or 
indirect phenomenon. 
 
CHD7 and retinoic acid signaling 
Conclusions 
 In Chapter 3, I investigated changes in SVZ gene expression upon loss of 
Chd7 as well as interactions between CHD7 and retinoic acid signaling.  I 
performed whole genome microarray analysis on microdissected SVZ from 
control and Chd7 knockout perinatal mice.  The majority of genes with changes 
in expression were down-regulated.  This abundance of down-regulated genes 
upon loss of Chd7 is not entirely surprising considering that this trend is observed 
in several cell types and further strengthens the hypothesis that CHD7 acts a 
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potent activator of gene expression (Layman et al. 2011; Hurd et al. 2012).  Gene 
ontology (GO) analysis revealed that down-regulated genes were involved in 
memory, cognition, neuronal differentiation, neuronal migration and neuronal 
maturation, which inform future studies of CHD7 function in brain regions that 
regulate these complex processes such as the cortex and dentate gyrus of the 
hippocampus.  Consistent with studies presented in Chapter 2, Rarb and Rxrg 
were down-regulated which further strengthens the connection between CHD7 
and retinoic acid signaling.  In nuclear extract derived from P19 embryonal 
carcinoma cells, CHD7 physically interacts with retinoic acid receptors.  To study 
Chd7 function in a cell line that is more amenable to genetic and biochemical 
manipulation (Soprano et al. 2007), I used Chd7 shRNA constructs based on the 
SIBR shRNA system to knockdown Chd7 in P19 embryonal carcinoma cells (Yu 
et al. 2005).  Knockdown of Chd7 led to reduced expression of known CHD7 
target genes and a decrease in P19 cell growth consistent with previously 
published growth studies (Kita et al. 2012).  These studies have provided 
preliminary evidence that CHD7 may regulate neuronal migration and maturation.  
This further strengthens the genetic and biochemical link between CHD7 and 
retinoic acid signaling.  Considering the striking similarity in phenotypes between 
CHARGE syndrome and retinoic acid deficiency (Sanlaville et al. 2006; Legendre 
et al. 2012; Rhinn et al. 2012), determination of the specific molecular 
mechanisms of CHD7 regulation of retinoic acid signaling may provide 
therapeutic interventions to potentially correct some CHARGE phenotypes 




 I observed CHD7 binding directly to retinoic acid receptors by co-
immunoprecipitation and found that Rarb and Rxrg expression are specifically 
down-regulated upon loss of Chd7.  A confounding factor in the co-
immunoprecipitation experiment is that I used a pan-retinoic acid receptor 
antibody that recognizes all three receptor isoforms.  To identify the specific 
receptor isoforms that CHD7 binds, co-immunoprecipitation experiments should 
be repeated utilizing antibodies that specifically identify RARα, RARβ, RARγ, 
RXRα, RXRβ and RXRγ.  After individually identifying which receptor isoforms 
CHD7 binds, one could determine whether CHD7 binds a specific RAR/RXR 
heterodimer.  Similar to the ChIP-seq experiments proposed above, it is 
necessary to determine whether specific retinoic acid receptor isoforms co-
localize at CHD7 bound genes in wild type mouse SVZ or P19 embryonal 
carcinoma neurospheres.  These experiments would help determine which 
specific retinoic acid receptor isoforms help mediate CHD7 gene regulation and 
mediate CHD7 effects on pro-neuronal or RA-target gene expression.  
Additionally, it is necessary that all experiments involving RA signaling be 
performed both with and without retinoic acid treatment to determine if the 
association of CHD7 and RA signaling components is truly retinoic acid-
dependent.  Overall, CHD7 appears to be regulating gene expression of retinoic 
acid signaling modulators as well as potentially participating in RA-mediated 
gene regulation by binding RAR’s.  The CHD7 and RAR/RXR ChIP-seq 
experiments proposed in this chapter will help address whether CHD7 is co-
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localizing with RAR/RXR complexes at pro-neural and RA-target genes at 
RARE’s.  The data presented in this dissertation lead me to hypothesize that 
CHD7 is likely functioning by binding to and activating the expression of RAR and 
RXR genes, not through direct association with RAR/RXR complexes at RA-
target genes. 
 The studies outlined in this dissertation regarding retinoic acid signaling 
have largely been performed on microdissected SVZ tissue or P19 
neurospheres, but have not assessed effects of Chd7-deficiency on retinoic acid 
signaling in vivo.  Using Nestin-CreERT2 and the Chd7flox allele (Ables et al. 
2010; Hurd et al. 2010; Madisen et al. 2010), one could induce knockout of Chd7 
in SVZ neural stem cells and investigate changes in localization of Rarb and 
Rxrg expression by in situ hybridization.  This would test whether reduced 
expression observed by qRT-PCR and microarray also occurs in vivo.  
Alternatively, crossing the RARE-lacZ reporter (a reporter allele that activates β-
galactosidase expression driven by a promoter with a retinoic acid response 
element) with wild type or Chd7-deficient mice would allow for monitoring of 
changes in activation of retinoic acid signaling in the SVZ (Rossant et al. 1991; 
Rajaii et al. 2008).  Experiments utilizing the RARE-LacZ would only determine if 
Chd7-deficiency leads to general dysfunction in RA signaling and would not 
directly identify whether abnormal localization or intensity of LacZ signal is 
directly due to loss of CHD7 protein at RARE elements of RA-target genes or 
due to a global reduction in RAR and RXR protein.   
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Considering that modulation of retinoic acid signaling in Chd7-deficient 
neurospheres rescues defects in proliferation, self-renewal and neuronal 
differentiation, it would be interesting to determine whether intraventricular 
injection of retinoic acid or the retinoic acid synthesis inhibitor citral corrects the 
proliferative and neurogenic defects observed in Chd7-deficient mice and 
neurospheres.  Overall, these studies would provide insight into the specific 
interactions between CHD7 and retinoic acid signaling to regulate pro-neuronal 
gene expression the SVZ neural stem cell niche. 
 
CHD7 and corticogenesis 
Conclusions 
 In Chapter 4, I investigated the role of CHD7 function in the development 
of the cerebral cortex, a brain region populated by neurons born in the SVZ.  As 
in the adult SVZ, CHD7 co-localized with markers of neural stem and progenitor 
cells during corticogenesis.  There were no changes in SVZ proliferation or 
apoptosis in the Chd7-deficient embryonic forebrain.  In Chd7-deficient 
neurospheres derived from embryonic forebrain, there was a mild decrease in 
neurosphere size which was rescued by inhibition of retinoic acid signaling by 
citral.  Interestingly, there were no changes in neurosphere self-renewal or 
neuronal differentiation.  These data show that Chd7 is expressed during 
corticogenesis, yet it does not appear to regulate neural stem and progenitor cell 
function between embryonic day 11 and embryonic day 15.  Further study of 
CHD7 function is necessary to determine what role, if any, CHD7 plays during 
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 While I have characterized the co-localization of CHD7 with a number of 
neural stem and progenitor cell markers, I did not explore its presence in 
neuroblasts and immature and mature cortical neurons.  Double 
immunofluorescence at embryonic days 13 and 15 in the forebrain with CHD7 
and neuroblast markers (DCX, Neurod1), immature neuron markers (TBR1) and 
mature neuron markers (CALB, CALR, TH) would reveal the complete spectrum 
of cell type-specific Chd7 expression in the forebrain.  These populations of cells 
are of particular interest due to their reduction in the Chd7-deficient SVZ neural 
stem cell niche and our microarray data showing that neuronal migration and 
maturation genes are down-regulated upon loss of Chd7 (Feng et al. 2013; 
Micucci et al. 2013).  Neuronal migration and maturation defects in Chd7-
deficient forebrain could be observed by immunofluorescence and counting of 
neuroblasts as they migrate to their appropriate cortical layers and mature 
cortical GABAergic and dopaminergic neurons.   Additionally, considering that 
the cortex consists of several distinct neuron layers, it would be interesting to see 
if this layering is disrupted in Chd7 conditional knockout mice compared to 
controls.  Abnormal layering would greatly affect the normal neural circuitry 
present in the cortex and could potentially lead to defects in information 
processing.  Finally, microarray or RNA-seq analysis of the SVZ and cortex in 
148 
 
control and Chd7-deficient embryos would potentially reveal differentially 
expressed genes that are important for neuronal development.  These studies 
would provide a basis for understanding the role of CHD7 in the development of 
the mammalian cortex and may give insight into some of the sensory and 





Ables, J. L., N. A. Decarolis, M. A. Johnson, P. D. Rivera, Z. Gao, D. C. Cooper, 
F. Radtke, J. Hsieh and A. J. Eisch (2010). "Notch1 is required for 
maintenance of the reservoir of adult hippocampal stem cells." J Neurosci 
30(31): 10484-10492. 
Bajpai, R., D. A. Chen, A. Rada-Iglesias, J. Zhang, Y. Xiong, J. Helms, C. P. 
Chang, Y. Zhao, T. Swigut and J. Wysocka (2010). "CHD7 cooperates 
with PBAF to control multipotent neural crest formation." Nature 
463(7283): 958-962. 
Bartels, C. F., C. Scacheri, L. White, P. C. Scacheri and S. Bale (2010). 
"Mutations in the CHD7 gene: the experience of a commercial laboratory." 
Genetic testing and molecular biomarkers 14(6): 881-891. 
Bouazoune, K. and R. E. Kingston (2012). "Chromatin remodeling by the CHD7 
protein is impaired by mutations that cause human developmental 
disorders." Proc Natl Acad Sci U S A 109(47): 19238-19243. 
Delahaye, A., Y. Sznajer, S. Lyonnet, M. Elmaleh-Berges, I. Delpierre, S. 
Audollent, S. Wiener-Vacher, A. L. Mansbach, J. Amiel, C. Baumann, D. 
Bremond-Gignac, T. Attie-Bitach, A. Verloes and D. Sanlaville (2007). 
"Familial CHARGE syndrome because of CHD7 mutation: clinical intra- 
and interfamilial variability." Clinical genetics 72(2): 112-121. 
Engelen, E., U. Akinci, J. C. Bryne, J. Hou, C. Gontan, M. Moen, D. Szumska, C. 
Kockx, W. van Ijcken, D. H. Dekkers, J. Demmers, E. J. Rijkers, S. 
Bhattacharya, S. Philipsen, L. H. Pevny, F. G. Grosveld, R. J. Rottier, B. 
Lenhard and R. A. Poot (2011). "Sox2 cooperates with Chd7 to regulate 
genes that are mutated in human syndromes." Nat Genet 43(6): 607-611. 
Feng, W., M. A. Khan, P. Bellvis, Z. Zhu, O. Bernhardt, C. Herold-Mende and H. 
K. Liu (2013). "The Chromatin Remodeler CHD7 Regulates Adult 
Neurogenesis via Activation of SoxC Transcription Factors." Cell Stem 
Cell 13(1): 62-72. 
Ghai, R., R. J. Falconer and B. M. Collins (2012). "Applications of isothermal 
titration calorimetry in pure and applied research--survey of the literature 
from 2010." Journal of molecular recognition : JMR 25(1): 32-52. 
Hartshorne, T. S., T. L. Grialou and K. R. Parker (2005). "Autistic-like behavior in 
CHARGE syndrome." Am J Med Genet A 133A(3): 257-261. 
Hurd, E. A., J. A. Micucci, E. N. Reamer and D. M. Martin (2012). "Delayed 
fusion and altered gene expression contribute to semicircular canal 
defects in Chd7 deficient mice." Mech Dev 129(9-12): 308-323. 
Hurd, E. A., H. K. Poucher, K. Cheng, Y. Raphael and D. M. Martin (2010). "The 
ATP-dependent chromatin remodeling enzyme CHD7 regulates pro-neural 
gene expression and neurogenesis in the inner ear." Development 
137(18): 3139-3150. 
Issekutz, K. A., J. M. Graham, Jr., C. Prasad, I. M. Smith and K. D. Blake (2005). 
"An epidemiological analysis of CHARGE syndrome: preliminary results 
from a Canadian study." Am J Med Genet A 133A(3): 309-317. 
150 
 
Kita, Y., M. Nishiyama and K. I. Nakayama (2012). "Identification of CHD7S as a 
novel splicing variant of CHD7 with functions similar and antagonistic to 
those of the full-length CHD7L." Genes Cells 17(7): 536-547. 
Kriegstein, A., S. Noctor and V. Martinez-Cerdeno (2006). "Patterns of neural 
stem and progenitor cell division may underlie evolutionary cortical 
expansion." Nat Rev Neurosci 7(11): 883-890. 
Layman, W. S., E. A. Hurd and D. M. Martin (2011). "Reproductive dysfunction 
and decreased GnRH neurogenesis in a mouse model of CHARGE 
syndrome." Hum Mol Genet 20(16): 3138-3150. 
Legendre, M., M. Gonzales, G. Goudefroye, F. Bilan, P. Parisot, M. J. Perez, M. 
Bonniere, B. Bessieres, J. Martinovic, A. L. Delezoide, F. Jossic, C. Fallet-
Bianco, M. Bucourt, J. Tantau, P. Loget, L. Loeuillet, N. Laurent, B. Leroy, 
H. Salhi, N. Bigi, C. Rouleau, F. Guimiot, C. Quelin, A. Bazin, C. Alby, A. 
Ichkou, R. Gesny, A. Kitzis, Y. Ville, S. Lyonnet, F. Razavi, B. Gilbert-
Dussardier, M. Vekemans and T. Attie-Bitach (2012). "Antenatal spectrum 
of CHARGE syndrome in 40 fetuses with CHD7 mutations." J Med Genet 
49(11): 698-707. 
Lledo, P. M., M. Alonso and M. S. Grubb (2006). "Adult neurogenesis and 
functional plasticity in neuronal circuits." Nat Rev Neurosci 7(3): 179-193. 
Lledo, P. M., F. T. Merkle and A. Alvarez-Buylla (2008). "Origin and function of 
olfactory bulb interneuron diversity." Trends Neurosci 31(8): 392-400. 
MacPherson, P. A., S. Jones, P. A. Pawson, K. C. Marshall and M. W. McBurney 
(1997). "P19 cells differentiate into glutamatergic and glutamate-
responsive neurons in vitro." Neuroscience 80(2): 487-499. 
Madisen, L., T. A. Zwingman, S. M. Sunkin, S. W. Oh, H. A. Zariwala, H. Gu, L. 
L. Ng, R. D. Palmiter, M. J. Hawrylycz, A. R. Jones, E. S. Lein and H. 
Zeng (2010). "A robust and high-throughput Cre reporting and 
characterization system for the whole mouse brain." Nat Neurosci 13(1): 
133-140. 
McBurney, M. W. (1993). "P19 embryonal carcinoma cells." Int J Dev Biol 37(1): 
135-140. 
McBurney, M. W., K. R. Reuhl, A. I. Ally, S. Nasipuri, J. C. Bell and J. Craig 
(1988). "Differentiation and maturation of embryonal carcinoma-derived 
neurons in cell culture." J Neurosci 8(3): 1063-1073. 
Micucci, J. A., W. S. Layman, E. A. Hurd, E. D. Sperry, S. F. Frank, M. A. 
Durham, D. L. Swiderski, J. M. Skidmore, P. C. Scacheri, Y. Raphael and 
D. M. Martin (2013). "CHD7 and retinoic acid signaling cooperate to 
regulate neural stem cell and inner ear development in mouse models of 
CHARGE syndrome." Hum Mol Genet. 
Rajaii, F., Z. T. Bitzer, Q. Xu and S. Sockanathan (2008). "Expression of the 
dominant negative retinoid receptor, RAR403, alters telencephalic 
progenitor proliferation, survival, and cell fate specification." Dev Biol 
316(2): 371-382. 
Rhinn, M. and P. Dolle (2012). "Retinoic acid signalling during development." 
Development 139(5): 843-858. 
151 
 
Rossant, J., R. Zirngibl, D. Cado, M. Shago and V. Giguere (1991). "Expression 
of a retinoic acid response element-hsplacZ transgene defines specific 
domains of transcriptional activity during mouse embryogenesis." Genes 
Dev 5(8): 1333-1344. 
Sanlaville, D., H. C. Etchevers, M. Gonzales, J. Martinovic, M. Clement-Ziza, A. 
L. Delezoide, M. C. Aubry, A. Pelet, S. Chemouny, C. Cruaud, S. 
Audollent, C. Esculpavit, G. Goudefroye, C. Ozilou, C. Fredouille, N. Joye, 
N. Morichon-Delvallez, Y. Dumez, J. Weissenbach, A. Munnich, J. Amiel, 
F. Encha-Razavi, S. Lyonnet, M. Vekemans and T. Attie-Bitach (2006). 
"Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 
truncating mutations correlates with expression during human 
development." J Med Genet 43(3): 211-217. 
Soprano, D. R., B. W. Teets and K. J. Soprano (2007). "Role of retinoic acid in 
the differentiation of embryonal carcinoma and embryonic stem cells." 
Vitam Horm 75: 69-95. 
Takada, I., M. Mihara, M. Suzawa, F. Ohtake, S. Kobayashi, M. Igarashi, M. Y. 
Youn, K. Takeyama, T. Nakamura, Y. Mezaki, S. Takezawa, Y. Yogiashi, 
H. Kitagawa, G. Yamada, S. Takada, Y. Minami, H. Shibuya, K. 
Matsumoto and S. Kato (2007). "A histone lysine methyltransferase 
activated by non-canonical Wnt signalling suppresses PPAR-gamma 
transactivation." Nat Cell Biol 9(11): 1273-1285. 
Yu, J. Y., T. W. Wang, A. B. Vojtek, J. M. Parent and D. L. Turner (2005). "Use of 
short hairpin RNA expression vectors to study mammalian neural 
development." Methods Enzymol 392: 186-199. 
Zentner, G. E., P. J. Tesar and P. C. Scacheri (2011). "Epigenetic signatures 
distinguish multiple classes of enhancers with distinct cellular functions." 
Genome Res 21(8): 1273-1283. 
 
 
 
